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INTRODUCTION
3D printing is quite possibly the next greatest chapter in
the industrial revolution, and the technology is moving rapidly.
In his 2013 State-of-the-Union Address, President Obama
observed that 3D printing . . . has the potential to
revolutionize the way we make almost everything.1 3D
printing, also known by the more technical term additive
manufacturing, has been around since the 1980s.2 In the past
few years, however, the technology has developed rapidly as
the prices of 3D printers have dropped substantially.3 3D
printing is already in the process of becoming a significant
industry with tremendous innovative potential for many
applications, from dental4 and medical,5 to automotive,6
 The authors would like to thank Reed Smith LLP attorneys Farah
Tabibkhoei and Lisa Baird for their hard work and assistance in putting
together this article. This article is an expansion of several chapters of a Reed
Smith white paper that the authors substantially contributed to as editors and
chapter authors. See JIM BECK ET AL., 3D PRINTING OF MEDICAL DEVICES:
WHEN A NOVEL TECHNOLOGY MEETS TRADITIONAL LEGAL PRINCIPLES 1519
(Colleen Davies et al. eds., 1st ed. 2014), https://www.reedsmith.com/files
/Publication/130448b9-7565-4295-a697-5c5d7c6eb516/Presentation/Publica
tionAttachment/9ba9b53c-2009-488d-ba91-5cc5a19a38f7/3d-printing-white-
paper_79444049.pdf. A second edition of the white paper, which expands on
the legal issues involved with 3D printing, and includes an updated tort
liability chapter, was published in December 2016. See JIM BECK ET AL., 3D
PRINTING OF MANUFACTURED GOODS: AN UPDATED ANALYSIS (Lisa Baird et
al. eds., Dec. 2016) [hereinafter 3D PRINTING OF MANUFACTURED GOODS],
https://www.reedsmith.com/files/Publication/4f5bee57-afd8-48cd-b2d1-
8f94fd6a0bd2/Preview/PublicationAttachment/b7819f50-37ae-4ee3-b15c-
90a7a58b02d9/3D-Printing-White-Paper-Final-2nd-Edition-December-
2016.pdf.
1. President Barack Obama, State of the Union Address (Feb. 12, 2013)
(transcript available at https://www.whitehouse.gov/the-press-office/2013/02
/12/remarks-president-state-union-address).
2. Cecile J. Gonzalez, The Engineering Behind Additive Manufacturing
and the 3d Printing Revolution, NATL SCI. FOUND. (Dec. 3, 2013),
https://www.nsf.gov/discoveries/disc_summ.jsp?cntn_id=129780 (discussing
the discovery and patenting of three different additive manufacturing
techniques in the 1980s).
3. Nick Bilton, Disruptions: On the Fast Track to Routine 3-D Printing,
N.Y. TIMES: BITS (Feb. 17, 2013, 11:00 AM) http://bits.blogs.nytimes.com/2013
/02/17/disruptions-3-d-printing-is-on-the-fast-track/ (The price of 3-D printers
has also dropped sharply over the last two years, with machines that once cost
$20,000, now at $1,000 or less.).
4. C. Lee Ventola, Medical Applications for 3D Printing: Current and
Projected Uses, 39 PHARM. & THERAPEUTICS 704, 70610 (2014); see also Lily
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aerospace/aviation,7 toys,8 military,9 fashion,10 food,11
eyewear,12 and construction.13 In other ways 3D printing is also
Hay Newman, This Guy Fixed His Teeth for Cheap with Homemade, 3-D
Printed Retainers, SLATE: FUTURE TENSE (Mar. 16 2016), http://www.slate
.com/blogs/fututense/2016/03/16/njit_student_3_d_printed_retainers_to_straig
hten_his_teeth.html.
5. Ventola, supra note 4; see also discussion in 3D Printing and Its
Impact on Medical Device and Health Care, infra Part IV.
6. Aaron M. Kessler, A 3-D Printed Car, Ready for the Road, N.Y. TIMES,
(Jan. 15, 2015), http://www.nytimes.com/2015/01/16/business/a-3-d-printed-car
-ready-for-the-road.html. Testing and prototyping is currently the most
common use of 3D printing by automobile manufacturers. Cf. Nick Bunkley,
Auto Industry Uses 3-D Printing Heavily in Product Development,
AUTOMOTIVE NEWS (Oct. 27, 2014, 12:01 AM), http://www.autonews.com
/article/20141027/OEM06/310279987/auto-industry-uses-3-d-printing-heavily-
in-product-development. Many automobile manufacturers use 3D printers to
manufacture component parts. See, e.g., Ford, Fords 3D-Printed Auto Parts
Save Millions, Boost Quality, (Dec. 12, 2013), https://media.ford.com/content
/fordmedia/fna/us/en/news/2013/12/12/ford_s-3d-printed-auto-parts-save-
millions--boost-quality.pdf. Ford employs 3D printing technology to print the
engine cover for the new Mustangs, engine components for the Fusion, and the
exhaust manifolds for the F-150. Id.; see also Bunkley, supra (noting the next-
generation Mercedes-Benz S class is predicted to have [3D-]printed trim
pieces such as air vents and speaker grilles . . . ). Audi recently announced
that their use of metal-based 3D printing is imminent, and that they had even
produced a fully 3D-printed functional replica of the 1936 Auto Union Type C
Grand Prix racer. See David K. Gibson, Audis 3D Printer Works in Metal,
BBC: THE ROUNDABOUT BLOG (Nov. 5, 2015), http://www.bbc.com/autos/story
/20151105-audis-3d-printer-works-in-metal. Local Motors is working on crash-
testing a 3D-printed car, which is printed with carbon-fiber-reinforced plastic
body and components using a 3D printer machine. See LOCAL MOTORS: LM3D,
https://localmotors.com/3d-printed-car/ (last visited Apr. 27, 2016).
7. For an example of a major aviation manufacturer using 3D printing,
see Dan Simmons, Airbus Had 1,000 Parts Printed to Meet Deadline, BBC
(May 6, 2015), http://www.bbc.com/news/technology-32597809. GE Aviation is
printing over 100,000 fuel nozzles for use in jet engines that will start flying in
2016. See GE Aviation, Additive Manufacturing, GEN. ELEC., http://www
.geaviation.com/company/additive-manufacturing.html (last visited Aug. 27,
2016) (noting that the nozzles are created using Direct Metal Laser Melting
and are approximately 25% lighter than their non-printed counterparts and
are less labor intensive and wasteful to create). Boeing has been using 3D
printing technology for approximately a decade and has used over 20,000 3D-
printed parts in non-critical applications. Frank Catalano, Boeing Files Patent
for 3D-Printed Aircraft Parts  And Yes, Its Already Using Them, GEEKWIRE
(Mar. 6, 2015, 11:23am), http://www.geekwire.com/2015/boeing-files-patent-
for-3d-printing-of-aircraft-parts-and-yes-its-already-using-them/; Brian
Krassenstein, Twenty-Thousand 3D Printed Parts Are Currently Used on
Boeing Aircraft as Patent Filing Reveals Further Plans, 3DPRINT.COM (Mar. 7,
2015), https://3dprint.com/49489/boeing-3d-print/.
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8. Now children can make their own toys at home. See, e.g., Edward C.
Baig, Mattel Resurrects ThingMaker as a 3D Printer, USA TODAY, (Feb. 13,
2016), http://www.usatoday.com/story/tech/columnist/baig/2016/02/12/mattel-
resurrects-thingmaker-3d-printer/80236104/ (reporting that the plastic used
by the ThingMaker is a kind of plastic, which is durable and non-toxic, and
allows children to create their own designs or designs made by others).
9. See Andrew Ward, U.S. Military Poised to Capitalize on 3-D Printing,
AOL (Jan. 21, 2015), http://www.aol.com/article/2015/01/21/military-testing-3d
-printing/21131090/; see also Eric Randolph, 3D Printing Could Revolutionize
Modern Warfare, BUS. INSIDER (Jan. 5, 2015, 8:54 PM), http:// www
.businessinsider.com/afp-how-3d-printing-could-revolutionise-war-and-foreign-
policy-2015-1.
10. E.g. Eddie Krassenstein, Nike Files Patent for Printing onto 3D
Objects with Unique 3D Printer, 3DPRINT.COM (Oct. 24, 2014), http://3dprint
.com/18990/nike-3d-printing-patent/. Adidas has a 3D-printed shoe, which is
to enter the marketplace in 2016, and is customized to the consumers foot and
exact specifications. See Adidas Breaks the Mould with 3D-Printed
Performance Footwear, ADIDAS GROUP (Oct. 7, 2015), http://www.adidas-group
.com/en/media/news-archive/press-releases/2015/adidas-breaks-mould-3d-
printed-performance-footwear/. The Adidas 3D-printed shoe was given to
certain 2016 Olympic athletes in the Summer of 2016. Nick Hall, Adidas
Rewards Medal Winners with 3D Printed Shoe, 3D PRINTING INDUSTRY (Aug.
17, 2016), https://3dprintingindustry.com/news/adidas-rewards-medal-winners
-3d-printed-shoe-93944/. In January of 2016, a student at Cornell received the
Geoffrey Beene National Scholarship from the YMA Fashion Scholarship
Fund for his 3D-printed line of interchangeable and recyclable clothing.
Michelle Matisons, Cornell Student Wins Fashion Industry Scholarship for
Sustainable 3D Printed Clothing Line, 3DPRINT.COM (Jan. 22, 2016), https://
3dprint.com/116168/sustainable-3d-clothing-line/.
11. See generally Jasper L. Tran, 3-D Printed Food, 17 MINN. J.L. SCI. &
TECH. 855, 87179 (2016) (describing hypothetical scenarios of legal liability
arising from 3D-printed foods); see also Matt McFarland, Five Amazing Ways
3-D-Printed Food Will Change the Way We Eat, WASH. POST: INNOVATIONS
(Jan. 28, 2015), http://www.washingtonpost.com/blogs/innovations/wp/2015/01
/28/5-amazing-ways-3d-printed-food-will-change-the-way-we-eat/; 3D Printing:
Food in Space, NASA (May 23, 2013), http://www.nasa.gov/directorates
/spacetech/home/feature_3d_food_prt.html (noting that NASA is exploring the
possibility of 3D printing food in space); Jacopo Prisco, Foodini Machine Lets
You Print Edible Burgers, Pizza, Chocolate, CNN: MAKE, CREATE, INNOVATE
(Dec. 31, 2014), http://www.cnn.com/2014/11/06/tech/innovation/foodini-
machine-print-food/ (describing a new product from a Barcelona-based startup
that allows the consumer to print spaghetti products); Marty Sliva, CES 2015:
We Ate 3D-Printed Pizza, IGN ENT. (Jan. 8, 2015), http://www.ign.com/articles
/2015/01/08/ces-2015-we-ate-3d-printed-pizza (reporting that an annual
Consumer Electronics Show in Las Vegas featured 3D-printed pizza).
12. See PROTOS EYEWEAR, http://www.protoseyewear.com/ (last visited
Oct. 8, 2016); David Sher, Taking a Closer Look at the 3D Printed Eyewear
Market, 3D PRINTING INDUSTRY (Sept. 8, 2014), http://3dprintingindustry.com
/2014/09/08/taking-closer-look-3d-printed-eyewear-business/.
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making its mark on manufacturing by reducing shipping and
production costs, spawning innovation (often upwards from the
consumer level), reducing logistical footprints, and allowing for
almost limitless potential uses.14 Because 3D printing is
revolutionizing how products are made, the materials used, and
who is the maker, this technology is not only stirring up the
industry,15 but also the law.16 As 3D printing develops, the law
will also have to develop in order to continue to maintain its
relevance.17
One of the biggest legal areas where 3D printing will have
an impact is tort liability.18 The legal implications will include
what is exactly a product, who is the manufacturer, what is
13. Michelle Star, Worlds First 3D-Printed Apartment Building
Constructed in China, CNET: TECH CULTURE (Jan. 19, 2015), http://www.cnet
.com/news/worlds-first-3d-printed-apartment-building-constructed-in-china/;
Michelle Star, Gravity-Defying 3D Printer to Print Bridge over Water in
Amsterdam, CNET: TECH CULTURE (June 14, 2015), http://www.cnet.com
/news/gravity-defying-3d-printer-to-print-bridge-over-water-in-amsterdam/.
14. See JOHN HAGEL III ET AL., DELOITTE CTR. FOR EDGE, THE FUTURE OF
MANUFACTURING: MAKING THINGS IN A CHANGING WORLD 1617 (2015),
http://dupress.deloitte.com/dup-us-en/industry/manufacturing/future-of-
manufacturing-industry.html. 3D printing also has policy implications.
President Obama launched the National Additive Manufacturing Innovation
Institute in August 2012 in an effort to foster collaboration among industry,
universities, and the federal government, and provide infrastructure that will
support innovation regarding 3D printing technologies and products. Press
Release, Office of the Press Secy, The White House, We Cant Wait: Obama
Administration Announces New Public-Private Partnership to Support (Aug.
16, 2012), https://www.whitehouse.gov/the-press-office/2012/08/16/we-can-t-
wait-obama-administration-announces-new-public-private-partners; see also
Stratasys Heads to the Hill to Demonstrate the New Shape of Manufacturing,
STRATASYS: 3D PRINTING (Oct. 17, 2014), http://blog.stratasys.com/2014/10/17
/3d-printing-capitol-hill.
15. See Eric Lindenfeld, 3D Printing of Medical Devices: CAD Designers as
the Most Realistic Target for Strict, Product Liability Lawsuits, 85 UMKC L.
REV. 80, 84 (2017) (Despite some of the challenges facing 3D printing of
medical devices, the future is bright for the industry, and it is expected to
grow at a nearly 15% rate to about $2.13 billion by 2020, with the bio-printing
market worth nearly $6 billion.).
16. See Patrick J Comerford & Erik P. Belt, 3DP, AM, 3DS and Product
Liability, 55 SANTA CLARA L. REV. 821, 82530, 832, 83536 (2015) (predicting
ways in which 3D printing will interact with the law of strict liability, implied
warranty, negligence, contracts, regulations, and insurance and calling for
industry leaders in 3D printing to anticipate legal liability stemming from
new technology).
17. See id.
18. See 3D PRINTING OFMANUFACTURED GOODS, supra note , at 1422.
148 MINN. J.L. SCI. & TECH. [Vol. 18:1
the marketplace, and who should be potentially liable for a
defective 3D-printed product (once product is defined).19
These legal implications are only heightened for more complex
and technical products such as drugs and medical devices.20
Although it is unclear, at this point in the absence of precedent,
exactly how the law will change, what is certain is that the law
will need to adapt or change as 3D printing becomes
commonplace. 3D printing will have an impact on many legal
fields, including regulatory, intellectual property, insurance,
environmental, transportation, contacts, and imports/exports,21
but this article is limited to examining the legal and practical
considerations of 3D printing in the products liability realm.
I. OVERVIEW OF 3D PRINTING: WHAT IS 3D PRINTING
AND HOW DOES IT WORK?
Although the term 3D printing is the most common and
colloquial term used for the additive manufacturing process,
the term additive manufacturing actually encompasses seven
different types of manufacturing.22 In an effort to categorize
19. See id.
20. See id. at 1619.
21. See generally id. at 1519.
22. DSM Desotech Inc. v. 3D Sys. Corp., 749 F.3d 1332, 1336 (Fed. Cir.
2014) (Additive technology creates parts by building layer upon layer with
materials such as plastics, metals, or ceramics. Subtractive technology works
by starting with a block of material and then cutting away layers. Examples of
additive technology include STL [stereolithography, see infra note 149 and
accompanying text], fused deposition modeling, laser sintering, 3D printing,
direct metal laser sintering, and digital light processing. Computer
numerically controlled machining is an example of subtractive technology.);
see also EOS GmbH Electro Optical Sys. v. DTM Corp., No. SACV 00-1230
DOC (MLGx), SA CV 02-0449 DOC (MLGx), 2004 WL 5683723, at *1 (C.D.
Cal. Jan. 12, 2004) (There are several rapid prototyping methods, including
two processes generally known as stereolithography and selective laser
sintering. Both processes typically begin with designing a three dimensional
object, usually with the use of a computer assisted design program (CAD).
Once the design of the object is complete, the object can be fabricated using
either a stereolithography or laser sintering machine. In both machines, a
computer controlled laser beam is focused at certain parts of the material 
usually a liquid resin in a stereolithography machine and a powder in a laser
sintering machine  to create a perfect, solid cross-section of the object. The
laser is then directed to repeat the process to correspond with the second
cross-section. The process is repeated, hundreds or thousands of times until
the object takes shape.). An example of the differences is described in DSM
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these different types of additive manufacturing, the American
Society for Testing and Material (ASTM) has drafted standards
for each:
 Material extrusionmaterial is selectively dispensed
through a nozzle or orifice
 Material jettingdroplets of build material are
selectively deposited
 Binder jettinga liquid bonding agent is selectively
deposited to join powder materials
 Sheet laminationsheets of material are bonded to
form an object
 Vat photopolymerizationliquid photopolymer in a vat
is selectively cured by light-activated polymerization
 Powder bed fusionthermal energy selectively fuses
regions of a powder bed
 Directed energy depositionfocused thermal energy is
used to fuse materials by melting as the material is being
deposited23
Desotech, Inc. v. 3D Sys. Corp., No. 08 cv 1531, 2013 WL 389003, at *2 (N.D.
Ill. Jan. 31, 2013), affd, 749 F.3d 1332 (Fed. Cir. 2014):
[T]he parts industry include[s] producers of systems, materials
manufacturers, end users, and service bureaus. Service bureaus are
companies that own one or more additive fabrication technologies and
are hired by a company or an individual, either on a regular or
onetime basis, to build a product or prototype. End users either make
their own parts or buy them from service bureaus. Computer
Numerically Controlled (CNC) machining is an example of a
subtractive technology. CNC machining uses a classic milling
machine to remove material from a block of material by computer
numerical control. Additive fabrication or rapid prototyping is a
newer process that uses a computer CAD/CAM design to build a part
or prototype out of plastic, metal or other materials. Unlike
machining processes, which are subtractive, additive technologies join
together liquid, powder or sheet materials to form objects. The
following technologies are additive: fused deposition modeling
(FDM), laser sintering, 3D printing, direct metal laser sintering,
digital light processing (DLP) (operationally similar to
stereolithography), power-based technology, and electron beam
melting.
23. ASTMs Additive Manufacturing Technology Standards, ASTM INTL,
http://www.astm.org/Standards/additive-manufacturing-technology-standards
.html (last visited Apr. 27, 2016); see also Ventola, supra note 4, at 705.
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The technical aspects of a particular 3D printers
functioning depend on multiple factors, including the type of
additive manufacturing process, material, and the printer
being used; but the basic concept of additive manufacturing is
that objects are created layer by layereven though each layer
may be extremely minute.24 Behind the scenes, controlling the
shape of whatever object is being produced, is an electronic file
(usually a computer aided design (CAD) file or an image file
created by scanning an object) containing the data the printer
needs to give shape to the physical object being printed.25
In many respects, additive manufacturing is the inverse of
traditional subtractive manufacturing processes, where blocks
of material are whittled down until a final shape emerges (as
when a marble statue or ice sculpture is carved from a block).26
The basic principle of subtractive manufacturing is to start
with too much and remove what is not needed.27 Because
additive manufacturing only uses materials that are needed for
the final object, the process can be more efficient and cost-
effective, and waste can be reduced.28
Efficiency is hardly the only benefit derived from additive
manufacturing. Manufacturing objects layer by layer results in
products that can be made in one integrated piece, so that no
final assembly is required.29 Current 3D printers can use
different materials, including plastics, metal, ceramics, and
24. Lucas S. Osborn, Regulating Three-Dimensional Printing: The
Converging Worlds of Bits and Atoms, 51 SAN DIEGO L. REV. 553, 559 (2014);
GLENN H. SNYDER ET AL., DELOITTE UNIV. PRESS, 3D OPPORTUNITY IN
MEDICATION TECHNOLOGY: ADDITIVE MANUFACTURING COMES TO LIFE 2
(2014); MICHAEL WEINBERG, PUB. KNOWLEDGE, IT WILL BE AWESOME IF THEY
DONT SCREW IT UP: 3D PRINTING, INTELLECTUAL PROPERTY, AND THE FIGHT
OVER THE NEXT GREAT DISRUPTIVE TECHNOLOGY 2 (2010); Adam Thierer &
Adam Marcus, Guns, Limbs, and Toys: What Future for 3D Printing?, 17
MINN. J.L. SCI. & TECH. 805, 807 (2016) (detailing the 3D printing process).
25. See WEINBERG, supra note 24, at 3; see also Tran, supra note 11, at
858.
26. See Additive Manufacturing vs. Subtractive Manufacturing, CREATIVE
MECHANISMS (Jan. 4, 2016 10:07:39 AM), https://www.creativemechanisms
.com/blog/additive-manufacturing-vs-subtractive-manufacturing.
27. See Nicole D. Berkowitz, Strict Liability for Individuals? The Impact
of 3D Printing on Products Liability Law, 92 WASH. UNIV. L. REV. 1019, 1021
(2015) (In traditional manufacturing, metal and plastic parts are cut out from
larger sheets of material, resulting in the waste of up to 90% of the material.).
28. See JOHN HORNICK, 3D PRINTINGWILL ROCK THEWORLD 4 (2015).
29. WEINBERG, supra note 24, at 2.
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wood.30 New emerging materials are also being created for use
by 3D printers such as graphene, electrically conductive
materials, silicone, carbon fiber, regolith, and biomaterials.31 In
addition, 3D printing can produce shapes not even possible
using traditional manufacturing techniques.32
3D printing is revolutionary in other respects as well. It
allows products to be customized to an individuals needs or
tastes, a drastic departure from todays factories, which focus
on mass production and aim to produce identical, standardized
products in bulk.33 3D printing additionally allows for the
manufacture of customized components or replacement parts.34
Forecasters also predict that 3D printing will democratize
manufacturing, allowing every individual with the means to
buy a printer, the ability to become a manufacturer, potentially
with the ability to market his or her products to others.35
Already, individuals can upload their design to 3D printing
websites like Shapeways,36 which will market the product,
print ordered products with its 3D printer, and deliver them to
the purchaser.37 For medical devices, physicians are able to
customize medical devices to prepare for surgery,38 and also to
30. Osborn, supra note 24, at 559.
31. For a list of 3D printing materials, see 3D Printing Materials, 3DERS,
http://www.3ders.org/3d-printing-materials.html (last visited Oct. 19, 2016).
32. Austin Weber, 3D Printing Myths and Methods, ASSEMBLY (July 1,
2014), http://www.assemblymag.com/articles/92260-d-printing-myths-and-
methods.
33. CHRISTOPHER BARNATT, 3D PRINTING 15 (2d ed. 2014),
Explainingthefuture.com.
34. Id.; Thierer & Marcus, supra note 24, at 812.
35. BARNATT, supra note 33; see also Thierer & Marcus, supra note 24, at
80812 (And the Consumer Technology Association (CTA) reports that 3D
printer sales are expected to generate $152 million in total revenue
(wholesale) in 2016 in the U.S. (up thirty-eight percent over 2015).).
36. SHAPEWAYS, http://www.shapeways.com/ (last visited Nov. 2, 2016).
37. See BARNATT, supra note 33, at 16.
38. F. Rengier et al., 3D Printing Based On Imaging Data: Review Of
Medical Applications, 5 INTL J. COMPUTER ASSISTED RADIOLOGY & SURGERY
335, 337 (2010); Michael Molitch-Hou, 3D Ops to Conduct Largest Study on 3D
Printed Pre-Surgical Models Yet, 3D PRINTING INDUSTRY (Oct. 27, 2015),
http://3dprintingindustry.com/2015/10/27/3d-ops-to-conduct-largest-study-on-
3d-printed-pre-surgical-models-yet/; Michael Molitch-Hou, 3D Printed Kidney
Models Aid Surgery in First Peer-Reviewed Study, 3D PRINTING INDUSTRY
(July 8, 2014), http://3dprintingindustry.com/2014/07/08/3d-printed-kidney-
models-aid-surgery-first-peer-reviewed-study/.
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implant bespoke, patient-matched, medical devices into
patients bodies.39 In the future, it will be possible to print such
devices on demand at a hospital or even at the physicians own
office, giving the physician more control over treatment options
than ever before.40 3D printing is likely to also facilitate the
concept of open design, which will make it easier for the
design of products to evolve.41 Once a digital product design file
is made available to the public, others may modify the design.42
Existing items can be scanned to create a CAD or image file,
opening the door to potentially unlimited copying.43
Simply put, 3D printing is a potentially disruptive
technology, and we undoubtedly have not yet envisioned all the
changes it will bring. What assuredly can be foreseen, however,
is that 3D printing will present legal challenges in products
liability.
II. TRADITIONAL TORT LIABILITY
Products liability itself is a relatively less traditional area
of the common law, arising largely from the perceived need to
adapt the common law to account for the rise of mass-produced
products and long, impersonal supply chains. One strand of
products liability law originated in contract law, but until the
early 1960s most plaintiffs were prevented from recovering by
warranty-based legal rules that required plaintiff and
defendant to be in privity of contract.44 The first breach of the
39. Scott J. Grunewald, Bodycad Introduces Bodycad OnCall for Custom
3D Printed Orthopedic Implants and Restorations, 3DPRINT.COM (Apr. 10,
2016), https://3dprint.com/128905/bodycad-oncall-implants/; Richard Moss,
New 3D-Printing Tech Set to Enable Patient-Specific Medical Devices, NEW
ATLAS (Nov. 4, 2015); 3D Prints in Medicine, NATL INST. HEALTH,
http://3dprint.nih.gov/about/medicine (last visited Oct. 8, 2016).
40. Alison Diana, 3D Printing Reshapes Healthcare INFO. WK. (Feb. 20,
2014, 11:00 AM), http://www.informationweek.com/healthcare/mobile-and-
wireless/3d-printing-reshapes-healthcare/d/d-id/1113893 (discussing how 3D
printing will be able to positively affect patient care in the future through
increased customization).
41. BARNATT, supra note 33, at 17.
42. Id.
43. See, e.g., id. at 1819 (discussing how dentists are using 3D scanners
to store impressions of patients mouths for future replication via 3D printers
rather than storing huge quantities of plaster teeth molds).
44. See generally Winterbottom v. Wright, (1842) 152 Eng. Rep. 402, 403
(stating that, as a general rule, privity of contract is needed to bring a breach
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privity doctrine came in Macpherson v. Buick Motor Co.,45
holding that manufacturers could be liable for negligence
absent privity.46 Only in the 1960s were privity and a number
of other defenses generally eliminated by a new doctrine, strict
liability, introduced in Greenman v. Yuba Power Products,47
which held manufacturers liable without fault (negligence) for
injuries caused by defective products.48
In the United States, tort liability laws vary from state to
state, but in general most states tort liability laws are
grounded in negligence or strict liability (often both).49
Negligence and strict liability differ in that negligence is a
fault-based doctrine, while the very basis of strict liability is
that a manufacturer is liable for product defects regardless of
fault.50
As to strict liability, states that adhere to common-law
standards generally use either the Restatement (Second) of
Torts or Restatement (Third) of Torts, which summarize the
general principles of common law in the United States as to
tort law. Strict liability doctrine was first included in the
of contract claim); Greenman v. Yuba Power Products, Inc., 377 P.2d 897, 901
(Cal. 1963) (introducing strict liability doctrine in the realm of manufacturer
liability for defective products).
45. Macpherson v. Buick Motor Co., 111 N.E. 1050, 1053 (N.Y. 1916).
46. Id.
47. Greenman v. Yuba Power Products, Inc., 377 P.2d at 901.
48. Id.
49. See generally 2016 ALFA International Product Liability & Complex
Torts PG Product Liability Quick Reference Guide, ALFA INTL, http://www
.alfainternational.com/filebin/compendia/2016_ALFA_International_Product_
Liability__Complex_Tort_Quick_Reference_Guide_all_states_condensed.pdf
(last visited Oct. 9, 2016); RESTATEMENT OF TORTS §§ 281503 (1934)
(covering negligence law); RESTATEMENT OF TORTS §§ 50424 (1938) (covering
absolute liability law).
50. DAVID G. OWEN & MARY J. DAVIS, OWEN & DAVIS ON PRODS.
LIAB. § 5:29 (4th ed. 20142016) (It is elemental that the very basis of
negligence liability, whether in products liability or other tort law context, is
grounded on fault. In contrast, the very basis of strict products liability in tort
is the suppliers responsibility for harm caused by product defects regardless of
fault.) (emphasis in original).
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Restatement (Second) of Torts,51 and thereafter was widely
adopted.52
Under the Restatement (Second) of Torts, strict liability is
imposed as follows: [o]ne who sells any product in a defective
condition unreasonably dangerous to the user or consumer or to
his property is subject to liability for physical harm thereby
caused . . . if the seller is engaged in the business of selling
such a product . . . .53 On the other hand, the Restatement
(Third) of Torts defines strict liability as [o]ne engaged in the
business of selling or otherwise distributing products who sells
or distributes a defective product is subject to liability for harm
to persons or property caused by the defect.54 While both
definitions are similar, each restatement has a different test
on how to determine if a product is defective.55
The Restatement (Second) of Torts includes the consumer
expectations test. A product is defective under the
Restatement (Second) of Torts if it leaves the sellers hands, in
a condition not contemplated by the ultimate consumer, which
will be unreasonably dangerous to him.56 The product must be
dangerous to an extent beyond that which would be
contemplated by the ordinary consumer who purchases it, with
the ordinary knowledge common to the community as to its
characteristics.57 A risk-utility test also arose under the
Restatement (Second), and is adopted exclusively by the
Restatement (Third) of Tortsproviding that a product is
defective if it has a manufacturing or design defect, or if it is
accompanied by an inadequate instruction or warning.58
51. RESTATEMENT (SECOND) OF TORTS § 402A (AM. LAW INST. 1965).
52. See generally Comerford & Belt, supra note 16, at 82426. See
Lindenfeld, supra note 15, at 8687 (recounting the history leading to the
Restatement (Second)).
53. RESTATEMENT (SECOND) OF TORTS § 402A (AM. LAW INST. 1965).
54. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 (AM. LAW INST.
1998).
55. Compare RESTATEMENT (SECOND) OF TORTS § 402A cmt. g (AM. LAW
INST. 1965), with RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 12 (AM.
LAW INST. 1998).
56. RESTATEMENT (SECOND) OF TORTS § 402A cmt. g (AM. LAW INST.
1965).
57. Id. at cmt. i.
58. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. §§ 12 (AM. LAW. INST.
1998).
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Despite its strict liability title, determining whether a
product has a defective design or an inadequate warning
mimics the negligence inquiry. The Restatement (Third)
adopts a reasonableness (risk-utility balancing) test as the
standard for judging the defectiveness of product[s].59 Whether
the consumer expectations or risk-utility test (or neither) is
used depends on the jurisdiction,60 however, the threshold
inquiry to any strict liability analysis is whether a product is
defective.
Simply because a product is defective does not mean that
strict liability is imposed.61 Under both restatements, the
person or entity selling the defective product must be engaged
in the business of selling.62 The following are sellers under
the Restatement (Second) of Torts: a manufacturer of a product
for use or consumption or a wholesale or retail dealer or
distributor.63 Strict liability does not apply to the occasional
seller who does not manufacture or distribute a product as
part of its business.64 The basis for strict liability is
the special responsibility for the safety of the public undertaken by
one who enters into the business of supplying human beings with
products which may endanger the safety of their persons and
property . . . . [T]his basis is lacking in the case of the ordinary
59. Id. § 2 cmts. d, i.
60. States that currently use the consumer expectations test are:
Arkansas, Indiana, Kansas, Maryland, Nebraska, New Hampshire, North
Dakota, Oklahoma, Oregon, Rhode Island, Tennessee, Utah, Vermont, and
Wyoming. States that use the risk-utility test are: Alabama, Colorado,
Georgia, Idaho, Iowa, Kentucky, Louisiana, Massachusetts, Michigan,
Minnesota, New Jersey, New Mexico, New York, North Carolina, Ohio, South
Carolina, Texas, West Virginia, and Wisconsin. Some states use both tests:
Alaska, Arizona, California, Connecticut, Florida, Hawaii, Illinois, Mississippi,
Pennsylvania, and Washington. Finally, a few states use neither test:
Delaware, Maine, Missouri, Montana, Nevada, South Dakota, Virginia. See
generally PRODUCT LIABILITY DESK REFERENCE: A FIFTY-STATE COMPENDIUM
passim (Morton F. Daller ed., 2016) (reporting a 50-state survey of
jurisdictions adopting one or the other liability theory).
61. See RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 (AM. LAW INST.
1998); RESTATEMENT (SECOND) OF TORTS § 402A(1)(a) (AM. LAW INST. 1965).
62. See RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 (AM. LAW INST.
1998); RESTATEMENT (SECOND) OF TORTS § 402A(1)(a) (AM. LAW INST. 1965).
63. RESTATEMENT (SECOND) OF TORTS § 402A cmt. f (AM. LAW INST.
1965).
64. Id.; RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 cmt. c (AM.
LAW INST. 1998).
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individual who makes the isolated sale, and he is not liable . . . in the
absence of his negligence.65
Under the Restatement (Third) of Torts, strict liability
applies only to manufacturers and other commercial sellers
and distributors who are engaged in the business of selling or
otherwise distributing the type of product that harmed the
plaintiff.66 It is not necessary that a commercial seller or
distributor be engaged exclusively or even primarily in selling
or otherwise distributing the type of product that injured the
plaintiff, so long as the sale of the product is other than
occasional or casual.67 Whether a defendant is a commercial
seller or distributor . . . is . . . a question of law to be
determined by the court.68 While the definitions set forth in
either restatement of seller seem straightforward, in recent
decades casually sold products have increased,69 blurring the
lines between commercial and occasional sellers.70
65. RESTATEMENT (SECOND) OF TORTS § 402A cmt. f (AM. LAW INST.
1965).
66. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 cmt. c (AM. LAW
INST. 1998).
67. Id.
68. Id.
69. See N.C. Dept of Commerce,What is Selling Online?, NC BROADBAND,
http://northcarolinadeportal.com/sellingonline/what-is-selling-online/ (last
visited Oct. 15, 2016) (giving guidance to individuals and businesses on how
they can sell online and stating that online sales steadily increased from 2002
to 2012). For example, companies like eBay, Amazon, and Etsy make it easy
for causal sellers to enter the marketplace. See AMAZON SERVICES,
https://services.amazon.com/content/sell-on-amazon.htm (last visited Oct. 15,
2016); EBAY, http://www.ebay.com/sl/sell (last visited Oct. 15, 2016); ETSY,
https://www.etsy.com/sell (last visited Oct. 15, 2016).
70. Courts in New York and Pennsylvania have already applied broad
definitions of seller. The New York Supreme Court has held [u]nder the
strict products liability doctrine as it exists in New York, defendants can be
manufacturers, distributors, retailers, processors and makers of component
parts who sell the product alleged to have caused injury, in essence, those
responsible for placing the defective product in the marketplace. Nickel v.
Hyster Co., 412 N.Y.S.2d 273, 274 (N.Y. Sup. Ct. Spec. Term 1978) (internal
citations omitted). A court in Pennsylvania held
under our products liability law, all suppliers of a defective product in
the chain of distribution, whether retailers, partmakers, assemblers,
owners, sellers, lessors, or any other relevant category, are potentially
liable to the ultimate user injured by the defect. This rule of law
ensures the availability of compensation to the injured party, and
helps place the burden of such injury on parties who, unlike the
consumer, have a better opportunity to control the defect or spread its
costs through pricing.
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Manufacturers also have a duty to warn end users of their
products about the risks of using the product or the proper use
of the product.71 This duty is the same in negligence and strict
liability because both theories require that the product
contain[ ] a danger that is unreasonable.72 Failing to supply
adequate warnings causes the product itself to be defective.73
While this is the general rule,74 there are certain exceptions.
For drugs or medical devices, the learned intermediary doctrine
provides that a manufacturer need only warn a prescribing
doctor about the risks, rather than an end user.75 Also a
supplier of a component part has no duty to warn end-users of
possible dangers from integrating the part into another product
(unless the component part is defective or the supplier
substantially participates in the design of the product).76 The
rationale of both of these exceptions is that an intermediary
is in a better position to understand or transmit the
appropriate warning.77
Finally, manufacturers or suppliers may face claims
sounding in contract for breach of warranty, either express or
implied.78 Express warranties are usually in a contract or other
document from the sale of a product.79 Implied warranties
usually provide that the goods are merchantable if the seller is
a merchant with respect to goods of that kind, unless excluded
Burch v. Sears, Roebuck & Co., 467 A.2d 615, 621 (Pa. Super. Ct. 1983)
(internal citations omitted).
71. OWEN & DAVIS, supra note 50.
72. Id.
73. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 cmt. a (AM. LAW
INST. 1998).
74. See id.
75. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 6(d) (AM. LAW INST.
1998). For the status of the learned intermediary doctrine in the 50 states, see
James M. Beck, Headcount: Whos Adopted the Learned Intermediary Rule?,
DRUG & DEVICE L., (July 5, 2007), https://www.druganddevicelawblog.com
/2007/07/headcount-whos-adopted-learned.html.
76. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 5 (AM. LAW INST.
1988).
77. Id. § 5 cmt. a (explaining that manufacturers may not know how their
product is further integrated with others); id. § 6 cmt. b.
78. See generally U.C.C. §§ 2-313 to -314 (AM. LAW INST. & UNIF. LAW
COMMN 2014).
79. Id. § 2-313.
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or modified.80 Subject to state-specific statutory limitations,
liability may be imposed on any party in the manufacturing,
selling or distributive chain.81
Although these general concepts have existed for decades,
the question remains whether they will be able to adapt to new
technologies, including 3D printing.
III. THE INTERSECTION OF TORT LIABILITY AND 3D
PRINTING
The nature of additive manufacturing presents substantial
challenges for traditional tort liability, since it democratizes
the manufacturing process.82 With access to a 3D printer and
CAD files, anyone can manufacture a product.83 Since
traditional products liability is keyed to the manufacturing
function,84 it is ill-suited to address products manufactured by
non-traditional sources, such as 3D printing stores, public
libraries, hospitals, or even end-use consumers. In particular,
traditional strict liability would provide no relief at all to an
end user injured by a 3D-printed product manufactured by the
users own 3D printera situation that, now rare, will become
increasingly commonplace as 3D printers follow home
computers into the mass market.85
80. Id. § 2-314(1).
81. See, e.g., Passaretti v. Aurora Pump Co., 607 N.Y.S.2d 688, 689 (N.Y.
App. Div. 1994); Picker X-ray Corp. v. Frerker, 405 F.2d 916, 919 (8th Cir.
1969) (applying Missouri law); Huebert v. Federal Pac. Elec. Co., 494 P.2d
1210, 1214 (Kan. 1972); Safeway Stores, Inc. v. L. D. Schreiber Cheese Co.,
326 F. Supp. 504, 509512 (W.D. Mo. 1971), revd on other grounds, 457 F.2d
962 (8th Cir. 1972); Volkswagen of Am., Inc. v. Novak, 418 So. 2d 801, 803
(Miss. 1982); Szrama v. Alumo Prods. Co., Inc., 462 N.Y.S.2d 156, 159 (N.Y.
Sup. Ct. 1983); Vintage Homes, Inc. v. Coldiron, 585 S.W.2d 886, 888 (Tex.
Civ. App. 1979); Western Equipment Co., Inc., v. Sheridan Iron Works, Inc.,
605 P.2d 806, 808 (Wyo. 1980).
82. See, e.g., John Newman, The Virtual Foundry Democratizes 3D Metal
Printing, RAPID READY TECH (July 6, 2016), http://www.rapidreadytech.com
/2016/07/the-virtual-foundry-democratizes-3d-metal-printing/.
83. See generally What is 3D Printing?, 3DPRINTING.COM, http://
3dprinting.com/what-is-3d-printing/ (last visited Oct. 15, 2016).
84. See, e.g., RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 (AM. LAW
INST. 1998); RESTATEMENT (SECOND) OF TORTS § 402A (AM. LAW INST. 1965).
85. See id. This is because there would be nobody who sold,
manufactured, or distributed the defective item to the end user and therefore
nobody to hold liable for the defect.
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When consumers begin to print medical devices at home, the
courts will face new and unexplored legal issues in product liability
suits. . . . [C]ourts will need to define which party manufactured
such a product: was it the consumer who printed the object or the
company that designed the code used to print it? Are two separate
products involved . . . or just one? If only one product is involved,
then has it substantially changed throughout the 3-D printing
process? These are only some of the questions that are bound to arise
in future cases.86
As warranty liability under the Uniform Commercial Code
is predicated on the defendant being a seller of goods,87 so too
is strict liability expressly based on the defendant being a
supplier of a product.88 To the extent that traditional
manufacturers use additive manufacturing as simply a new
production technique, and continue to sell 3D-printed products
through traditional supply chains, liability for such products
will not change significantly.89 To the extent, however, that 3D
printers are operated by other entitiesspecialty 3D printing
stores, professionals using products in the performance of their
services, parts suppliers, hobbyists, and most disruptively, end
use consumersstrict liability as it has been applied since the
Restatement (Second) was published in 1965 is unlikely to
provide remedies to persons injured by 3D-printed products.90
Factual issues, which in turn have legal implications, also
complicate products liability with respect to 3D-printed
86. Kelly E. Jones & Jacqueline Cavallaro, Hot Off the 3-D Press: Additive
Manufacturings Effect on Medical Device Companies, DRI: THE VOICE (Mar.
2, 2016), portal.criticalimpact.com/newsletter/newslettershow5.cfm
?contentonly=1&content=28496&id=3459.
87. U.C.C. § 2-314 (AM. LAW INST. & UNIF. LAW COMMN 2014).
88. Section 402A is entitled Special Liability of Seller of Product for
Physical Harm to User or Consumer and provides that
[o]ne who sells any product in a defective condition unreasonably
dangerous to the user or consumer or to his property is subject to lia-
bility for physical harm thereby caused to the ultimate user or con-
sumer, or to his property, if . . . the seller is engaged in the business
of selling such a product.
RESTATEMENT (SECOND) OF TORTS § 402A(1)(a) (AM. LAW INST. 1965).
89. See generally RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 (AM.
LAW INST. 1998); RESTATEMENT (SECOND) OF TORTS § 402A (AM. LAW INST.
1965).
90. See generally RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 (AM.
LAW INST. 1998); RESTATEMENT (SECOND) OF TORTS § 402A (AM. LAW INST.
1965).
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products. CAD files for 3D-printed products already are
available, either for purchase or for free, over the internet.91
The likely absence of any brick and mortar supplier will
complicate liability, as these internet sellers may well not be
amenable to jurisdiction, have assets available to satisfy
judgments, or even be identifiable in some cases.92 Nor will the
creator of the CAD file used to make the product necessarily be
identifiable.93 The CAD file may well be open source,94 so that
any number of anonymous persons may have contributed to its
coding.95 An unknown person may have reverse-engineered a
CAD file for someone elses product by digitizing it using a 3D
scanner.96 Of course, given the nature of the internet, the CAD
file may have been pirated and uploaded without the
knowledge or permission of whoever originally created it, and
the pirate may or may not have removed the original designers
91. See, e.g., FABBLY, http://www.fabbly.com/ (last visited Oct. 15, 2016);
Find, Share, and Sell 3D Print Files, PINSHAPE, https://pinshape.com/ (last
visited Oct. 15, 2016); SHAPEWAYS, supra note 36; THINGIVERSE,
http://www.thingiverse.com/ (last visited Oct. 15, 2016).
92. Scott Cameron, You Cant Buy Personal Jurisdiction on eBay, IP L.
BLOG (Dec. 3, 2008), http://www.theiplawblog.com/2008/12/articles/cyberspace-
law/you-cant-buy-personal-jurisdiction-on-ebay/; see Problems with Online
Shopping, FINDLAW, http://consumer.findlaw.com/consumer-transactions
/problems-with-online-shopping.html (last visited Oct. 15, 2016) ([W]hen you
buy something online from an individual vendor, perhaps through Craigslist
or a similar service, it could prove very difficult to resolve such an issue if the
seller is acting in bad faith or otherwise not responsive.).
93. Cf. Problems with Online Shopping, supra note 92 (noting the
difficulty of a buyer seeking reimbursement when an online seller acts in bad
faith or is unresponsive).
94. See OPEN SOURCE INITIATIVE, https://opensource.org/about (last
visited Apr. 27, 2016) (Open source enables a development method for
software that harnesses the power of distributed peer review and
transparency of process. The promise of open source is higher quality, better
reliability, greater flexibility, lower cost, and an end to predatory vendor lock-
in.); see also NIH 3D PRINT EXCHANGE, 3dprint.nih.gov/about (last visited
Apr. 27, 2016) (allowing 3D-printed designs for prosthetics, among other
things, to be shared).
95. See, e.g., Discover 3D Models, NIH 3D PRINT EXCHANGE,
3dprint.nih.gov/discover (last visited Apr. 27, 2016).
96. See generally Lyndsey Gilpin, 8 Things You Need to Know About 3D
Scanners, TECHREPUBLIC (Apr. 14, 2015), http://www.techrepublic.com/article
/8-things-you-need-to-know-about-3d-scanners/ (detailing how a 3D scanner is
utilized).
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identifying information.97 Thus, simultaneously with
separating design from manufacturing, additive manufacturing
will also lead to an explosion in the availability of anonymously
designed products.98
The advent of 3D printing has multiplied the number of
possible products and manufacturers and thereby is poised
to scramble the traditional manufacturer-based chain-of-sale
concept on which strict liability has been based.99 Possible
scenarios in which defects in 3D-printed products might arise
include:
(1) The original product used to create the initial digital
design was defective;
(2) The original CAD file digital design was defectively
created;
(3) A defect was introduced into the CAD file as it was
uploaded to a file-sharer;
(4) The CAD file was corrupted during the process of
downloading from a file-sharer;
(5) The defect was caused by some problem or defect in
the 3D printer;
(6) The defect was caused by some problem or defect in
the bulk or raw material used in 3D printer to create the
product;100
97. Is My AutoCAD Genuine?, AUTODESK, http://www.autodesk.com
/solutions/software-piracy/autocad (last visited Oct. 15, 2016); see also
Insurance Implications of 3D Printing, ZURICH INSIDER (Aug. 22, 2013), http://
insider.zurich.co.uk/market-expertise/insurance-implications-of-3d-printing/
(If you are a designer, for instance, you have no control over how well a 3D
printing machine will make your product. There is also a risk with the quality
of the raw materials being used and potentially new combinations of materials
coming together, which have not been properly tested to do so.).
98. See, e.g., NIH 3D PRINT EXCHANGE, supra note 95.
99. 3-D Printed Products, Product Liability and Insurance Implications,
KENNEDYS (June 2, 2014), http://www.kennedyslaw.com/article
/3dprintedproducts/ (Current product liability laws and regulations . . . may
not be suitably aligned to deal with the distribution of responsibility for
unsafe/defective 3-D printed products, as the technology develops.).
100. See Bolson Materials Intl, Inc. v. 3D Sys. Corp., No. 5:14-cv-01441,
2016 WL 5661613 (N.D. Ohio, Sept. 30, 2016) (considering a contract claim
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(7) Human error in implementing the digital design caused
the defect; and
(8) Human error in using the 3D printer and/or materials
caused the defect.101
Moreover, this list likely understates the potential range of
3D printing defect situations by not including reverse-
engineering through use of 3D scanners.102 Litigation involving
reverse-engineered products will have to include scanner-
reflected defects among the defect possibilities.
The new 3D printing technology, and the new internet-
based supply chains that it spawns, will almost certainly force
a redefinition of the parameters of tort liability, particularly
where traditional manufacturing processes are carried out by
entities elsewhere in the chain of sale. Identifiable entities,
particularly those with presumptive deep pockets, will be
facing attempts to expand theories of liability. Negligence,
particularly with its flexible reasonableness and
foreseeability concepts, could well make a comeback.
Attempts to impose liability on non-manufacturer designers
even in cases where their designs have been piratedcan be
expected.103 The definition of what is a product is likely to
come under pressure.
over contaminated filaments intended for use in 3D printers, and further
demonstrating the possibility for products liability claims over defective raw
materials from similar sets of facts).
101. See id. 3D printing will cause insurance issues, because as 3D
printing blurs the line between manufacturers and consumers, it will create
challenges in apportioning liabilities and pose accountability and traceability
issues. Whether the injury will be covered by an insurer is a separate issue.
Consider, for example, a hobbyist who sells an object that was printed in his
garage, which causes injuries to a customer. An issue will exist as to whether
there will be coverage under the individuals homeowners insurance policy,
which typically contains a business exclusion, which bars coverage for
activities carried out for financial gain. As one insurer stated, regarding
claims arising from 3D-printed devices, we are aware of no claims having
been reported yet, so we dont know exactly what will happen. We have no
precedent. Cindy Slubowski, 3-D Printing: Who is Responsible?, ZURICH (Aug.
25, 2014), https://www.zurichna.com/en/knowledge/articles/2014/08/3d-
printing-who-is-responsible.
102. See generally Gilpin, supra note 96.
103. See Lindenfeld, supra note 15, at 9394 (recognizing that designers
not involved in the manufacturing process have traditionally not been held
strictly liable, and citing Christian v. Minn. Mining & Mfg. Co., 126 F. Supp.
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A. IS AN ELECTRONIC 3D PRINTING FILE A PRODUCT?
Taking the last question first, what counts as a product
when it comes to 3D printing? Certainly a physical object
produced through 3D printing seems to fit within traditional
concepts of product.104 Beyond what comes out of the printer,
3D printing requires CAD files, as well as code to operate the
printer.105 Whether this software would also be considered a
product is questionable.106 Courts have yet to extend
products liability theories to bad software, computer viruses, or
web sites with inadequate security or defective design.107
Purely electronic data, such as code, does not constitute a
product, under the Restatement (Third) of Torts, which
defines a product as tangible personal property distributed
commercially for use or consumption.108 The Restatement
2d 951, 957 (D. Md. 2001) (holding developer of product that it no longer
manufactured cannot be strictly liable); In re Minn. Breast Implant Litig., 36
F. Supp. 2d 863, 872 (D. Minn. 1998) (holding designer not liable under strict
liability principles)).
104. See generally RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 19 (AM.
LAW INST. 1998).
105. See, e.g., 3D Modeling Tools, 3D PRINTING FOR BEGINNERS,
http://3dprintingforbeginners.com/software-tools/ (last visited Apr. 27, 2016)
(listing software for CAD, modeling, and sculpting tools as well as software for
operating 3D printers that is available for purchase/download).
106. See generally RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 19 (AM.
LAW INST. 1998). It is tenuous whether this software is tangible personal
property, and also whether it is being distributed commercially under the
Restatement (Third)s analysis. Commentators tend to be ahead of precedent
in this respect. See Lindenfeld, supra note 15, at 9499 (stating that CAD
designers may be the most realistic target for defects in 3D-printed
products); David W. Lannetti, Toward A Revised Definition of Product Under
the Restatement (Third) of Torts: Products Liability, 55 BUS. LAW. 799, 816
(2000) ([M]any scholars have advocated the inclusion of computer software
under the aegis of section 402A products.).
107. James A. Henderson, Tort vs. Technology: Accommodating Disruptive
Innovation, 47 ARIZ. ST. L.J. 1145, 116566 n.135 (2015) (citation omitted).
108. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 19 (AM. LAW INST.
1998) (emphasis added); accord RAYMOND T. NIMMER, LAW OF COMPUTER
TECHNOLOGY §12:31 (2015) (stating that [a]n issue largely left unaddressed
in modern case law concerns whether computer software qualifies as a
tangible product, . . . . While the issue has yet to be addressed by courts, the
proper answer holds that most software does not fall within the purview of
product liability law under this definition); see also Am. Online, Inc. v. St.
Paul Mercury Ins. Co., 207 F. Supp. 2d 459, 467 (E.D. Va. 2002), affd, 347
F.3d 89 (4th Cir. 2003) (finding that tangible is something that can be
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(Third)s definition is based on the laws historic aversion to
imposing strict liability on printed information, particularly in
books and other publications,109 but it has been extended to
computer software.110
Courts across the country have held that publishers cannot
be liable for informational defects in published material
pursuant to the First Amendment.111 On the other hand,
touchednot an imperceptible piece of data or software that can only be
perceived with the help of a computer).
109. See RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 19 cmt. d (AM.
LAW INST. 1998) (Although a tangible medium such as a book, itself clearly a
product, delivers the information, the plaintiffs grievance in such cases is
with the information, not with the tangible medium. Most courts, expressing
concern that imposing strict liability for the dissemination of false and
defective information would significantly impinge on free speech have,
appropriately, refused to impose strict products liability in these cases.); see
also, e.g., Winter v. G.P. Putnams Sons, 938 F.2d 1033, 1036 (9th Cir. 1991);
Lewin v. McCreight, 655 F. Supp. 282, 28384 (E.D. Mich. 1987) (holding that
publisher did not have duty to warn of defective ideas supplied by third-
party authors); Way v. Boy Scouts of Am., 856 S.W.2d 230, 239 (Tex. App.
1993) (holding that the information conveyed by the magazine and shooting
sports supplement [were] not products within the meaning of the Restatement
(Second) of Torts) (emphasis omitted).
110. See, e.g., Sanders v. Acclaim Entmt, Inc., 188 F. Supp. 2d 1264, 1278
79 (D. Colo. 2002) (holding that computer games are not products for strict
liability purposes); Wilson v. Midway Games, Inc., 198 F. Supp. 2d 167, 173
(D. Conn. 2002) (indicating that interactive virtual reality technology is not
a [product] for the purposes of strict products liability); James v. Meow
Media, Inc., 90 F. Supp. 2d 798, 810 (W.D. Ky. 2000) (stating that [w]hile
computer source codes and programs are construed as tangible property for
tax purposes and as goods for UCC purposes, these classifications do not
indicate that intangible thoughts, ideas, and messages contained in computer
video games, movies, or internet materials should be treated as products for
purposes of strict liability), affd, 300 F.3d 683, 70001 (6th Cir. 2002)
(software makers and website operators did not deal in products). But see
generally Corley v. Stryker Corp., No. 6:13-CV-02571, 2014 WL 3375596 (W.D.
La. May 27, 2014) (holding that a cutting guide which was designed and
manufactured from patient-specific 3D imaging data . . . and the use of
proprietary 3D imaging software was treated as a product by the court),
adopted, Corley v. Stryker Orthopaedics, No. 132571, 2014 WL 3125990
(W.D. La. July 3, 2014), discussed infra note 139.
111. See James M. Beck, On Suing Publishers, DRUG & DEVICE L. (Apr. 7,
2011), https://www.druganddevicelawblog.com/2011/04/on-suing-publishers
.html. There are also other First Amendment implications of 3D printing, and
governments are beginning to regulate access to 3D printing goods, such as
weapons. Kyle Langvardt, Remarks on 3D Printing, Free Speech, and Lochner,
17 MINN. J.L. SCI. & TECH. 779, 786 (2016). Those regulations do not envision
consumers 3D printing the products, however, and are also likely run into the
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whether or not something is tangible does not necessarily
dictate whether it qualifies as a product for strict liability
purposes.112 For example, courts have held that certain non-
tangible items, such as electricity, qualify as products for
purposes of imposing strict liability.113 Maps and navigational
charts, particularly in the aeronautical context, have also been
held to be products.114 To date, case law is nonexistent on the
question whether the code for 3D printing designs constitutes a
product for purposes of products liability.115
Does 3D printing render parts of the Restatement (Third)
obsolete? Not necessarily.116 While neither the Restatements
black letter, nor its comments, mention computer code, the
same who is the manufacturer issues discussed infra. Id. at 78889.
Governments may also regulate CAD files for medical devices and drugs in the
future, since those products can also be considered dangerousalthough the
manufacturing issues will still likely remain.
112. See RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 19 cmt. d (AM.
LAW INST. 1998) (listing and discussing intangible items which qualify as
products for the purposes of tort liability).
113. See, e.g., id. (discussing general rule that electricity becomes a
product only when it passes through the customers meter); Smith v. Home
Light & Power Co., 695 P.2d 788, 789 (Colo. App. 1984) (adopting the holding
that electricity is a product); Schriner v. Penn. Power & Light Co., 501 A.2d
1128, 1133 (Pa. Super. Ct. 1985) (holding that electricity can be a product,
within the meaning of § 402A); Stein v. S. Cal. Edison Co., 7 Cal. App. 4th
565, 57071 (Cal. Dist. Ct. App. 1992).
114. See Brocklesby v. United States, 767 F.2d 1288, 1295 (9th Cir. 1985)
(holding that an aeronautical chart was a defective product for purposes of
analysis under section 402A); Saloomey v. Jeppesen & Co., 707 F.2d 671,
67677 (2d Cir. 1983) (indicating that, due to mass production and marketing,
navigational charts are products under section 402A thereby requiring that
the defendant bear the costs of proximately caused accidents); Fluor Corp. v.
Jeppesen & Co., 216 Cal. Rptr. 68, 7071 (Cal. Ct. App. 1985) (holding that an
instrument approach chart was a product subject to strict liability).
115. There are other non-products liability issues associated with
electronic files, such as viruses. See Peter Jensen-Haxel, 3D Printers, Physical
Viruses, & the Regulation of Cloud Supercomputing in the Era of Limitless
Design, 17 MINN. J.L. SCI. & TECH. 737, 76667 (2016). These concerns do
have an underlying effect on products liability, should a product be defective
due to a virus existing by reason of inadequate quality control. At the same
time, computer aided manufacturing does have benefits as it can help
alleviate concerns with hazardous building materials. Cf. id. at 77677
(describing how a fisherman will be able to custom print a net to minimize
ecological hazard).
116. See, e.g., RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 19,
reporters note to cmt. d, at 27879 (AM. LAW INST. 1998).
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possibility of products liability for electronic information is
discussed in the Reporters Notes:117
The Ninth Circuit suggested in dictum that computer software
might be considered a product for purposes of strict products liability
in tort.[118] . . . Although there are no cases on point on their facts,
numerous commentators have discussed the issue and urged that
software should be treated as a product.[119] . . .
When a court will have to decide whether to extend strict
liability to computer software, it may draw an analogy between the
treatment of software under the Uniform Commercial Code and
under products liability law. Under the Code, software that is mass-
marketed is considered a good.[120] . . . However, software that was
developed specifically for the customer is a service.[121]
117. Id. [Editors Note: The citations listed in footnotes 11821 below are
adapted from, and substantially similar to, those compiled in the Reporters
Notes comment d.]
118. Winter v. G.P. Putnams Sons, 938 F.2d 1033, 1036 (9th Cir. 1991)
(stating in dictum that [c]omputer software that fails to yield the result for
which it was designed may be another example of an intangible product).
119. See, e.g., Michael C. Gemignani, Product Liability & Software, 8
RUTGERS COMPUTER & TECH. L.J. 173, 19699 (1981); David A. Hall, Note,
Strict Products Liability & Computer Software: Caveat Vendor, 4
COMPUTER/L.J. 373 (1983); Jim Prince, Note, Negligence: Liability for
Defective Software, 33 OKLA. L. REV. 848, 855 (1980) (In terms of software,
[analysis of public policy considerations] . . . means that when software is
distributed to the public through mass merchandising, strict liability in tort
should be an available theory for a consumer who is injured because of a
defect in the software.); Susan Lanoue, Note, Computer Software & Strict
Products Liability, 20 SAN DIEGO L. REV. 439 (1983); Daniel J. Hanson, Note,
Easing Plaintiffs Burden of Proving Negligence for Computer Malfunction, 69
IOWA L. REV. 241 (1983).
120. See, e.g., Advent Sys. Ltd. v. Unisys Corp., 925 F.2d 670 (3d Cir. 1991)
(applying Pennsylvania law); RRX Indus., Inc. v. Lab-Con, Inc., 772 F.2d 543
(9th Cir. 1985) (applying California law); Wachter Mgmt. Co. v. Dexter &
Chaney, Inc., 144 P.3d 747, 750 (Kan. 2006); Olcott Intl & Co. v. Micro Data
Base Sys., Inc., 793 N.E.2d 1063, 1071 (Ind. Ct. App. 2003); Hou-Tex, Inc. v.
Landmark Graphics, 26 S.W.3d 103, 109 (Tex. App. 2000); Sys. Design &
Mgmt. Info., Inc. v. Kan. City Post Office, 788 P.2d 878 (Kan. App. 1990);
Rottner v. AVG Techs. USA, Inc., 943 F. Supp. 2d 222, 23031 (D. Mass.
2013). Recent amendments to the UCC, however, seem to be moving in the
opposite direction. The 2005 revisions to Article 2 exclude information from
the definition of goods and also define computer software as information. See
U.C.C. §§ 9-102, 2-105(1) (AM. LAW INST. & UNIF. LAW COMMN 2014).
121. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 19, at 27879,
reporters note to cmt. d, (AM. LAW INST. 1998); see, e.g., Data Processing Serv.,
Inc. v. L.H. Smith Oil Corp., 492 N.E.2d 314, 318 (Ind. Ct. App. 1986); Micro-
Managers, Inc. v. Gregory, 434 N.W.2d 97, 98 (Wis. Ct. App. 1988); Sys. Am.,
Inc. v. Rockwell Software, Inc., No. C 03-02232 JF (RS), 2007 WL 218242
(N.D. Cal. Jan. 26, 2007); Pearl Invs. LLC. v. Standard I/O, Inc., 257 F. Supp.
2017] 3D PRINTING & PRODUCTS LIABILITY 167
Notably, the UCC cases finding products to be goods
involve economic losses rather than personal injuries,122 and a
more recent uniform law reaches the opposite result.123
A non-products liability case, ClearCorrect Operating, LLC
v. International Trade Commission, addressed 3D printing
digital files specifically, and held that they are not material
things.124 In this case, a manufacturer of 3D-printed products
was sued for importing CAD files used in 3D printing, allegedly
in violation of the plaintiffs patent.125 The Federal Circuit held
that digital files used in 3D printing were not articles under
the Tariff Act of 1930126 because digital files were not
articles.127 Articles must be material things.128 Since CAD
files were not articles under the statute, no administrative
authority existed to stop their importation.129 Putting aside the
patent implications of this ruling,130 as to products liability, the
extensive discussion in ClearCorrect suggests, by analogy, that
2d 326, 35253 (D. Me. 2003); see also Bonna Lynn Horovitz, Note, Computer
Software as a Good Under the Uniform Commercial Code: Taking a Byte Out
of the Intangibility Myth, 65 B.U. L. REV. 129, 145 (1985); Edward G. Durney,
Comment, The Warranty of Merchantability and Computer Software
Contracts: A Square Peg Wont Fit in a Round Hole, 59 WASH. L. REV. 511, 523
(1984).
122. See Advent Sys. Ltd., 925 F.2d at 672; RRX Indus., Inc., 772 F.2d at
544; Wachter Mgmt. Co., 144 P.3d at 74950; Olcott Intl & Co., 793 N.E.2d at
1068; Sys. Design & Mgmt. Info., Inc., 788 P.2d at 879; Rottner, 943 F. Supp.
2d at 224.
123. Compare UNIF. COMPUT. & INFO. TRANSACTIONS ACT § 102(a)(35)
(NATL CONFERENCE OF COMMRS ON UNIF. STATE LAWS 2002) (defining
informationas opposed to goodsas including computer programs),
with id. § 102(a)(33).
124. ClearCorrect Operating, LLC v. Intl Trade Commn, 810 F.3d 1283,
1290 (Fed. Cir. 2015).
125. Id. at 1287.
126. Id. at 129094 (construing 19 U.S.C. § 1337).
127. Id.
128. Id. at 1293, 1296, 1299.
129. Id. at 129394, 1302 (For the reasons stated above, we reverse and
remand the [International Trade] Commissions decision, finding that the
Commission does not have jurisdiction over this case.).
130. For patent implications of 3D printing and other intellectual property
issues the technology raises, see Bryan J. Vogel, Intellectual Property &
Additive Manufacturing / 3D Printing: Strategies & Challenges of Applying
Traditional IP Laws to a Transformative Technology, 17 MINN. J.L. SCI. &
TECH. 881 (2016).
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digital files used in 3D printing may not themselves be
products, and that decision may stand.131
A similar ruling that computer code is not an aspect of a
tangible product was reached in United States. v.
Aleynikov,132 construing the National Stolen Property Act
(NSPA).133 The court held that proprietary computer source
code was not a stolen good within the meaning of this 1948-
vintage statute.134 The NSPA criminalizes only the illicit
movement of goods, wares, merchandise, securities or
money.135 The would-be good was source code allegedly
illegally uploaded by the defendant and transported across
state lines.136 The Second Circuit found that the source code
could not be goods, wares, or merchandise under the
statute, [b]ased on the substantial weight of the case law, as
well as the ordinary meaning of the words . . . .137 Intellectual
property alone is beyond the scope of the NSPA, which requires
that some tangible property must be taken from the owner for
there to be deemed a good that is stolen.138
A possible portent of how the law might shift is Corley v.
Stryker Corp., involving a customized, but non-3D-printed,
class II medical device that also featured electronic files and
patient-matched imaging data.139 The device was a single-use,
disposable, cutting guide[ ] designed and manufactured from
131. On March 31, 2016, the Federal Circuit Court of Appeals issued an
order denying petitions by the International Trade Commission (ITC) and
Align Technology, Inc. that had sought rehearing en banc of the Federal
Circuits opinion. ClearCorrect Operating, LLC v. Intl Trade Commn., 819
F.3d 1334, 1335 (Fed. Cir. 2016). The order was nearly unanimous, albeit with
Judge Pauline Newman filing a lengthy dissent. Id. at 133747. With a
rehearing and potential reversal by the full Federal Circuit bench now
officially off the table, only a reversal by the Supreme Court or an Act of
Congress can bring digital transmissions within the ITCs jurisdiction as
products.
132. United States v. Aleynikov, 676 F.3d 71, 76 (2d Cir. 2012).
133. 18 U.S.C. §§ 231415 (2012).
134. Aleynikov, 676 F.3d at 76.
135. 18 U.S.C. § 2314.
136. Aleynikov, 676 F.3d at 74.
137. Id. at 76.
138. Id. at 77 (citing United States v. Bottone, 365 F.2d 389, 393 (2d Cir.
1966)).
139. Corley v. Stryker Corp., No. 6:13-CV-02571, 2014 WL 3375596 at *1
(W.D. La. May 27, 2014), adopted, Corley v. Stryker Orthopaedics, No. 13-
2571, 2014 WL 3125990 (W.D. La. July 3, 2014).
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patient imaging data (MRI/CT).140 The cutting guide was
created by a software program from a three-dimensional model
of the patients anatomy using images obtained through an
MRI or CT scan.141 The programmable device allowed the
patients surgeon to make incisions tailored to the patients
specific anatomy and guided the positioning of certain other
components.142 The suit followed a limited recall because of
potential issues associated with internal processes for
planning cases.143 The Corley court allowed a design defect
products liability cause of action to survive a motion to
dismiss.144 The court found that the software used in creating
each cutting guide [was] a necessary part of the cutting
guide.145 Therefore, the plaintiffs allegations that the software
was defective sufficiently alleged that the cutting guide used
during [plaintiffs] surgery was unreasonably dangerous in
design due to the alleged software defects and could sustain a
products liability claim.146
Corley has implications for the software used to create
similarly customized 3D-printed medical devices, since both
use patient-matched images. Courts may now be willing to
stretch the definition of product to include electronic files
used to make bespoke 3D-printed objects, reasoning similarly
to Corley that the file is part and parcel of the completed
product and therefore subject to products liability laws. Thus, a
court encountering 3D-printed products liability type claims
may find that if the software or electronic file is defective, the
entire system is defective. Notably, Corley did not involve
separate manufacturers for the device and the software,147
which could complicate the analysis. On the other hand, using
140. See FOOD & DRUG ADMIN., 510(k) SUMMARY FOR SHAPEMATCH
CUTTING GUIDE, http://www.accessdata.fda.gov/cdrh_docs/pdf12/K122053.pdf.
141. See id.; see also Corley, 2014 WL 3375596, at *1.
142. See FOOD & DRUG ADMIN., supra note 140.
143. FOOD & DRUG ADMIN., CLASS 1 DEVICE RECALL SHAPEMATCH
CUTTING GUIDES, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES
/res.cfm?id=115791.
144. Corley, 2014 WL 3375596, at *4.
145. Id at *3.
146. Id. The plaintiffs warning claim also survived to the extent they
alleged that no warnings accompanied the product. Id. at *45.
147. Id. at *1.
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the same reasoning found in earlier cases,148 courts could also
support the conclusion that electronic StereoLithography (STL)
filesthe standard file type used by most additive
manufacturing systems149are not products under the
Restatements of Torts. If STL files are not products due to
intangibility, injured parties cannot pursue strict liability
claims, which require proof of a manufacturing defect, design
defect, or failure to warn with respect to a product, plus
causation and injury.150 Thus,
[t]he weight of authority, including case law, finds software is not
defined as a product for purposes of tort products liability. . . . The
imposition of strict products liability would have to be founded on
policy arguments sufficiently strong to overcome a wholly novel
extension of the doctrine to the arena of non-product intangibles.151
148. See, e.g., Sanders v. Acclaim Entmt, Inc., 188 F. Supp. 2d 1264, 1278
79 (D. Colo. 2002) (holding that computer games are not products for strict
liability purposes); Wilson v. Midway Games, Inc., 198 F. Supp. 2d 167, 173
(D. Conn. 2002) (indicating that interactive virtual reality technology is not
a [product] for the purposes of strict products liability); James v. Meow
Media, Inc., 90 F. Supp. 2d 798, 810 (W.D. Ky. 2000) (stating that [w]hile
computer source codes and programs are construed as tangible property for
tax purposes and as goods for UCC purposes, these classifications do not
indicate that intangible thoughts, ideas, and messages contained in computer
video games, movies, or internet materials should be treated as products for
purposes of strict liability), affd, 300 F.3d 683, 70001 (6th Cir. 2002)
(software makers and website operators did not deal in products).
149. 3D Sys., Inc. v. Formlabs, Inc., No. 13 CIV. 7973, 2014 WL 1904365,
at *1 (S.D.N.Y. May 12, 2014) (3D printers create physical three-dimensional
objects from a liquid medium involving the application of solid imaging
techniques, including stereolithographic techniques. Stereolithography is a 3D
printing technique that produce three-dimensional models or products by
curing a photo-reactive resin with a UV laser or other power source.)
(internal citation omitted).
150. See RESTATEMENT (SECOND) OF TORTS § 402A (AM. LAW INST. 1965);
RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. §§ 12 (AM. LAW INST. 1998).
151. Seldon J. Childers, Dont Stop the Music: No Strict Products Liability
for Embedded Software, 19 U. FLA. J.L. & PUB. POLY 125, 15152 (2008); see
also Langvardt, supra note 111, at 793 (When a noncompliant product causes
harm to a consumer, it is generally the manufacturers fault for making it
available, not the consumers for purchasing it. That approach avoids placing
the consumer in an uncertain position relative to the law, it insures that social
costs are borne by the party who is in the best position to avoid them, and it
avoids setting up senseless deterrents to productive economic transactions. It
is intuitive to carry the same approach over to an online mall of 3D-printable
goods, where the content provider steps into the shoes of the manufacturer
and distributor.).
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Such definitions of product, of course, would not preclude
negligence or (perhaps) UCC warranty liability,152 assuming
that the other elements of such causes of action were present.
Holding that a CAD file is a product would also have
significant practical consequences with respect to warnings.153
Product manufacturers have a well-established duty to warn
about product risks.154 If a CAD file is itself a product, then
presumably its manufacturer would have to include product
warnings in addition to the software necessary to 3D-print
whatever the file is intended to create.
Likewise, at the time of sale or distribution,155 a CAD file
is purely digital. The transition from an intangible digital file
to a tangible product may well be viewed as a substantial
change that precludes imposition of strict liability, since only a
tangible product is capable of causing injury.156
B. 3D PRINTING, A SERVICE OR GOOD?
As consumers continue to turn to 3D printing services157 to
print their productstransactions that combine products and
serviceswhether a plaintiff can recover for strict liability can
also turn on the defendants role.158 The purpose of imposing
152. In Rapid Models & Prototypes, Inc. v. Innovated Sols., Civil No. 14-
277 (NLH/KMW), 2015 WL 4914477, at *46, *78 (D.N.J. Aug. 18, 2015), the
court used common law warranty principles on a motion to dismiss related to
a 3D printer company. The court also found that the MagnusonMoss
Warranty Act (MMWA) would not apply because the printer was not a
consumer product as it was intended to create mass-produced items that
could be sold, and that Plaintiffs intended to use the printer in their business.
Id. at *67.
153. At least one commentator has suggested granting immunity to some
intermediaries from punishing forms of liability, or at least limit liability in
some fashion to avoid a chilling effect on innovation. Thierer & Marcus, supra
note 24, at 827.
154. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 2(c), § 2 cmts. im
(AM. LAW INST. 1998).
155. Id. § 2.
156. See RESTATEMENT (SECOND) OF TORTS §§ 402A(1)(b), 402A cmt. p
(AM. LAW INST. 1965).
157. See, e.g., Digitally Hand Crafted Personalized, 3D Printed Products,
SHAPEWAYS, http://www.shapeways.com/ (last visited Oct. 17, 2016).
158. For an explication of different roles in 3D printing, see Simon, Should
You Buy a 3D Printer or Use a 3D Printing Service?, 3DERS.ORG (June 28,
2015), http://www.3ders.org/articles/20150628-should-you-buy-a-3d-printer-or-
use-a-3d-printing-service-sculpteo-releases-2015-edition.html, and see also
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strict products liability on a commercial seller, manufacturer,
or distributor of products is to create safety incentives for
manufacturers that encourage[ ] greater investment in
product safety.159 Courts often decline to impose strict liability
on defendants whose primary objective is providing services.160
While a 3D printing service can control potential liability for its
customers injuries through exculpatory contractual
provisions,161 tort law will define a services liability to injured
third parties.
Product users seeking to recover for injuries resulting from
a 3D-printed product, under a strict liability theory, face an
additional hurdleproving that the product was placed on the
market by a commercial manufacturer or seller.162 Thus, a
hobbyist who occasionally uses 3D printing to make, for
example, a hard-to-obtain spare part, which then injures a
consumer, will not be subjected to strict liability, whereas an
entity that regularly makes, markets, distributes, and sells 3D-
printed products as part of its ongoing business activities will
be.163 Currently, many hobbyists are devoted to the restoration
and maintenance of historic automobiles and airplanes that
Jensen-Haxel, supra note 115, at 759 (Big box stores . . . have on-site 3D
printers for customers to print repair parts and [f]or high-end printing, one
can submit CAD files over the Internet to services that mail back parts in
ceramics and metals.).
159. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 2 cmt. a (AM. LAW
INST. 1998).
160. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 19(b) (AM. LAW INST.
1998).
161. E.g., Donald R. Ballman, Software Tort: Evaluating Software Harm by
Duty of Function and Form, 3 CONN. INS. L.J. 417, 419 (1997) ([U]nder
current law, software manufacturers can significantly limit, if not eliminate
any liability for damage which errors in their products create.).
162. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 cmt. c (AM. LAW
INST. 1998).
163. Heidi Nielson, Manufacturing Consumer Protection for 3-D Printed
Products, 57 ARIZ. L. REV. 609, 617 (2015); Nora Freeman Engstrom, 3-D
Printing and Product Liability: Identifying the Obstacles, 162 U. PA. L. REV.
ONLINE 35, 37 (2013), http://www.pennlawreview.com/essays/10-2013
/Engstrom.pdf. Generally, under existing products liability principles, so-
called occasional sellers of products are not subject to strict liability. See
RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1, reporters note to cmt. c, at
12 (AM. LAW INST. 1998).
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have not been in production for decades.164 Spare parts for out-
of-production vehicles are increasingly difficult to come by, so
such hobbyists will undoubtedly turn to 3D printing, either by
digitizing old blueprints or reverse engineering parts using 3D
scanners.165 If such parts fail, it is unlikely that their sellers
would face strict liability, unless they make a business out of
selling them.
Spare parts for most used vehicles, however, are a big
business, with original equipment manufacturers (OEM)
competing with aftermarket parts suppliers.166 Currently, parts
suppliers must maintain large inventories of parts to supply
the needs of owners of hundreds of different models of vehicles,
and often must scramble to obtain particularly rare parts from
junkyards.167 The prospect of reduced storage costs alone
makes refurbishing or replacing expensive [spare] parts . . . a
perfect job for some types of 3D printing.168 In the long term,
the replacement of large physical inventories of spare and
replacement parts with digitized libraries of CAD files for such
parts is probably inevitable.169
As long as the physical manufacturers of spare parts are
also the source of the CAD files, the 3D printing of such parts
164. See, e.g., AVANTI OWNERS ASSN INTL, INC., http://www.aoai.org/ (last
visited Oct. 17, 2016) (Studebaker Avanti); EDSEL OWNERS CLUB,
http://www.edselclub.org/ (last visited Oct. 17, 2016) (Ford Edsel); The North
American P-51 Mustang, MUSTANGSMUSTANGS, http://www.mustangs
mustangs.com/p-51/ (last visited Oct. 17, 2016) (North American P-51
Mustang).
165. E.g., Benedict, 3D Scanning and 3D Printing Put Rare Alfa Romeo
Tipo 33 3 Back on the Grid, 3DERS.ORG (Aug. 14, 2016), http://www.3ders.org
/articles/20160814-3d-scanning-and-3d-printing-put-rare-alfa-romeo-tipo-33-3-
back-on-the-grid.html.
166. Compare FORDPARTS, http://www.fordparts.com/ (last visited Oct. 17,
2016), with CAR-PART.COM, http://car-part.com/ (last visited Oct. 17, 2016).
167. Cf. Benjamin Preston, How to Find Used Car Parts, JALOPNIK (Jul.
20, 2012), http://jalopnik.com/5927827/how-to-find-used-car-parts (discussing
how to find used car parts and listing the junkyard as one possible place to
look).
168. HORNICK, supra note 28, at 92.
169. Cf. id. at 10506 (discussing 3Discovered, a company which seeks to
offer full digitized libraries of CAD files of parts to major manufacturers);
Benedict, 3D Printing Could Help Restore Out-of-Action US Marine Corps
Aircraft, 3DERS.ORG (July 30, 2016), http://www.3ders.org/articles/20160730-
3d-printing-could-help-restore-out-of-action-us-marine-corps-aircraft.html.
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will not change products liability litigation very much.170
However, anything that can be digitized can, and almost
certainly will, be pirated.171 Inevitably, CAD files for 3D
printing spare parts (and many other products) will be
available on internet file-sharing sites from sources other than
their original creators.
Companies may find their products competing not only with their
traditional competitors products, but also with copies of their own
products, with customized versions of their own products, with
generic substitutes . . . and with customized versions of generic
substitutes . . . . Such products could be made by professional
counterfeiters, 3D print shops, industrial customers, or
consumers.172
However, these alternative sources, many of which are
internet-based and often disreputable, are unlikely to be
amenable to suit in most cases. To the extent that the original
creator of a subsequently pirated CAD file is identifiable,173 it
may find itself faced with claims that it is liable for products
that it may have once designed, but that it neither
manufactured nor received any economic benefit from their
sale. While there would be no liability under traditional strict
liability principles, more expansiveand controversial
theories of liability, such as innovator liability,174 bare
170. Any products liability claim predicated on 3D printing would likely
involve examination of relevant CAD files, requiring additional expert
testimony relating to software issues, and possibly the use of software
diagnostics. Further, to the extent that such files are something of a black
box, not readily amenable engineering analysis, plaintiffs could be expected
to assert res ipsa loquitur or malfunction theories of liability. See
RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 3 (AM. LAW INST. 1998). Such
theories depend, however, on eliminating other causes of the malfunction.
Id. § 3(b). The existence of multiple actors would make excluding other
possible sources of the alleged defect difficult if not impossible. See 3-D
Printed Products, Product Liability and Insurance Implications, supra note 99.
171. HORNICK, supra note 28, at 15859, 17577.
172. Id. at 159.
173. While there are various technological means for imbedding identifiers
in CAD files, the possibility of liability for injuries caused by products made
with pirated CAD files raises questions about the advisability of utilizing such
identification techniques.
174. This theory would hold makers of branded drugs liable for labeling
defects in other manufacturers largely identical generic drugs under
negligence or fraud theories based on foreseeability of loss. See Conte v.
Wyeth, Inc., 85 Cal. Rptr. 3d 299, 30810 (Ct. App. 2008). Most courts have
rejected this liability theory. See James M. Beck, Innovator Liability at 100,
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metal liability,175 or some duty to guard against the
counterfeiting of ones product,176 exist that could be asserted
in such situations.
Even overcoming these obstacles, a plaintiff, to recover
under a strict liability theory, would have to show that the
product was defective at the time of sale or distribution.177
However, with the open source movement, where 3D designs
are shared with a community of users who are encouraged to
share and improve upon existing designs,178 plaintiffs may find
it virtually impossible to trace the design to its original owner
or show that it left a particular defendants control without
substantial change by the time it reached the consumer.179
Where 3D modeling and animation software is offered for free,
DRUG & DEVICE L. BLOG (July 18, 2014), https://www.druganddevicelawblog
.com/2014/07/innovator-liability-at-100.html.
175. This negligence theory is asserted in asbestos cases against makers of
durable non-asbestos containing products where it is foreseeable that their
products will be used in conjunction with difficult-to-identify asbestos-
containing products that wear out. Compare ONeil v. Crane Co., 266 P.3d 987
(Cal. 2012), with Simonetta v. Viad Corp., 197 P.3d 127, 13138 (Wash. 2008),
with In re N.Y.C. Asbestos Litig., 59 N.E.3d 458 (N.Y. 2016), and May v. Air &
Liquid Sys. Corp., 129 A.3d 984 (Md. 2015) reconsideration granted in part
(Feb. 19, 2016).
176. See Jones v. Ram Med., Inc., 807 F. Supp. 2d 501, 510 (D.S.C. 2011);
Ashworth v. Albers Med., Inc., 410 F. Supp. 2d 471, 47677 (S.D. W. Va.
2005); Fagan v. AmerisourceBergen Corp., 356 F. Supp. 2d 198, 207, 21011
(E.D.N.Y. 2004); Arons v. Rite Aid Corp., No. BER-L-4641-03, 2005 WL
975462, at *1516 (N.J. Super. Ct. Law Div. Mar. 23, 2005).
177. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 2 (AM. LAW INST.
1998); accord RESTATEMENT (SECOND) OF TORTS § 402A(1)(b) (AM. LAW INST.
1965).
178. See, e.g., OPEN SOURCE INITIATIVE, supra note 94.
179. There is also the question of which design defect testrisk/utility or
consumer expectationshould be employed. Compare RESTATEMENT (THIRD)
OF TORTS: PRODS. LIAB. § 2 cmt. f (AM. LAW INST. 1998), with RESTATEMENT
(SECOND) OF TORTS § 402A cmt. i (AM. LAW INST. 1965). To the extent that the
3D-printed product is simple, such as a toy or household good, the consumer
expectation theory could apply. However, to the extent that anything about
the 3D printing process enters into the defect analysis, risk/utility would seem
to be the only applicable test, since consumers cannot be expected to have any
expectations about something as complex and esoteric as 3D printing. [A]
complex product, even when it is being used as intended, may often cause
injury in a way that does not engage its ordinary consumers reasonable
minimum assumptions about safe performance. Tincher v. Omega Flex, Inc.,
104 A.3d 328, 388 (Pa. 2014) (quoting Soule v. Gen. Motors Corp., 882 P.2d
298, 308 (Cal. 1994)).
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another basic strict liability and implied warranty
prerequisitethe saleis eliminated.180 Open source
software also is generally distributed subject to terms of use
that preclude recovery under products liability theories,181
although the applicability of such exculpatory language to
injuries suffered by third persons is dubious.
C. WILL NEGLIGENCE CLAIMSMAKE A COMEBACK?
Given the challenges associated with asserting a strict
liability claim in the context of 3D printing, plaintiffs seeking
to recover for personal injuries caused by additive
manufacturing may have little alternative except to pursue
negligence claims. To prevail on a negligence theory, a plaintiff
must prove the existence of a duty of care, breach of that duty,
factual and proximate causation, and resulting damages.182
The initial question is who owes a duty of care to the plaintiff.
For example, does the designer of the CAD file for the 3D-
printed product owe a duty of care to unknown third persons?
Whether a designer has a duty may depend on whether the
plaintiff suffered personal or economic injuries.183 Courts
applying the economic loss rule184 have held that software
developers do not have a duty of care to avoid intangible
economic loss or emotional distress, and thus cannot be liable
for negligence unless their software caused physical
damages.185 However, product designers or inventors who were
not also manufacturers of products have historically not been
180. RESTATEMENT (SECOND) OF TORTS § 402A(1) (AM. LAW INST. 1965);
U.C.C. § 2-314. The Restatement (Third) is not as restrictive, recognizing
liability for both sale or distribution of a product. RESTATEMENT (THIRD) OF
TORTS: PRODS. LIAB. § 2 (AM. LAW INST. 1998).
181. See, e.g., Terms of Service, OPEN SOURCE INITIATIVE, https://
opensource.org/ToS (last visited Oct. 17, 2016).
182. E.g., RESTATEMENT (THIRD) OF TORTS: LIAB. FOR PHYSICAL &
EMOTIONAL HARM § 6 cmt. b (AM. LAW. INST. 2010).
183. See RESTATEMENT (THIRD) OF TORTS: LIAB. FOR ECON. HARM § 3 (AM.
LAW. INST., Tentative draft No. 1, 2012).
184. See id.
185. E.g., In re Sony Gaming Networks & Customer Data Sec. Breach
Litig., 903 F. Supp. 2d 942, 96768 (S.D. Cal. 2012); Shema Kolainu-Hear Our
Voices v. ProviderSoft, LLC, 832 F. Supp. 2d 194, 20508 (E.D.N.Y. 2010);
Hou-Tex, Inc. v. Landmark Graphics, 26 S.W.3d 103, 107 (Tex. App. 2000);
Huron Tool & Engineering Co. v. Precision Consulting Serv., Inc., 532 N.W.2d
541, 54344 (Mich. Ct. App. 1995).
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held strictly liable for product defects.186 Other designers
architects, engineers, and the likewho provide design input,
but are not involved in manufacturing, may be liable in tort for
their negligence.187 Courts also have yet to hold manufacturers
of production equipment strictly liable for the products that
such equipment makes, which may limit the liability of 3D
printer manufacturers.188
Assuming that the manufacturer or seller of the 3D-
printed product has a duty of care, what does the duty entail
with respect to a 3D-printed product? Generally, a
manufacturer or seller has a legal duty to use reasonable care
in response to a foreseeable risk of injury to others.189 When a
manufacturer or seller knows or should know of unreasonable
dangers associated with the use of the product, the user is
likely to be unaware of such dangers, and a warning could
reduce possible harm, there is a duty to warn of the dangers.190
Applying these principles, CAD files, without more, may not
present unreasonable and unknown dangers triggering a duty
to warn. On the other hand, if a designer or seller distributes
CAD files on how to 3D-print a firearm, presumably a duty to
warn of the dangers of the gun arises.191 Whether a duty to
warn exists is likely to be a fact-driven inquiry and will depend
on the type of product being 3D-printed.
186. JAMES M. BECK & ANTHONY VALE, DRUG & MEDICAL DEVICE
PRODUCT LIABILITY DESKBOOK § 8.09 (2016).
187. E.g., Carl J. Circo, When Specialty Designs Cause Building Disasters:
Responsibility for Shared Architectural and Engineering Services, 84 NEB. L.
REV. 162, 17982 (2005); Constance Frisby Fain, Architect and Engineer
Liability, 35 WASHBURN L.J. 32, 3435 (1995).
188. Eric Lindenfeld & Jasper L. Tran, Strict Liability and 3D-Printed
Medical Devices, YALE J.L. & TECH. BLOG (Dec. 11, 2015), http://yjolt.org/blog
/2015/12/11/strict-liability-and-3d-printed-medical-devices.
189. See generally RESTATEMENT (THIRD) OF TORTS: LIAB. FOR PHYSICAL &
EMOTIONAL HARM § 7 (AM. LAW. INST. 2010).
190. Id. § 18.
191. But cf. id. § 18 cmt. f (commenting that even if most users would
generally appreciate the danger of guns there still may be a duty to warn
because it may be foreseeable that some faction of [users] will be lacking the
intelligence or the experience needed to appreciate the risk). CAD files for
firearms and other dangerous products already exist. HORNICK, supra note 28,
at 16972. 3D-printed bombs will follow soon. Id. at 177; see also Def.
Distributed v. U.S. Dept of State, 838 F.3d 451, 455 (5th Cir. 2016) (stating
that in the United States virtually anyone with access to a 3D printer [can]
produce 3D-printed firearms and gun parts).
178 MINN. J.L. SCI. & TECH. [Vol. 18:1
Another possible target of liability is the manufacturer of
the 3D printer. However, unless the 3D printer itselfas
opposed to 3D-printed productscauses injury,192 such liability
would be akin to holding makers of tools (such as industrial
robots or plastic extruders) liable for defects in whatever
products they make.193 There is no precedent for such broad
liability,194 and in analogous situations, such as multi-use
component parts, the law has refused to impose strict liability
for all of the multiple possible uses of a product.195 To impose
liability in this fashion, because innovative technology has
disrupted traditional buyer-seller relationships, would run
contrary to the products liability systems traditional
accommodations of innovative technology:
American products liability law does not generally countenance
second-guessing regarding the trade-offs embedded in the
disruptiveness, as such, of disruptive innovation. . . . [A] tort
plaintiff may attack disruptive new technology marginally by tacitly
accepting the disruptive aspects but arguing that the product design
before the court could have been made safer without rejecting the
innovative new category of which it is an example. But, distributors
of products based on disruptive innovation have nothing moreone
could plausibly argue they have lessto fear regarding the
possibility that their products will be found to be defectively
designed than do distributors of products based on established, time-
tested technology.196
Finally, 3D printing may provide opportunities to reduce
products liability exposure in some traditional products. As one
commentator has observed, the ability of additive
192. See RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 1 (AM. LAW.
INST.1998). If the printer itself caused injury the liability would be no
different than any other product.
193. See Lindenfeld & Tran, supra note 188.
194. There has yet to be a test case for liability where a nondedicated
robotic platform caused physical harm. M. Ryan Calo, Open Robotics, 70 MD.
L. REV. 571, 576 (2011) (footnote omitted); see also F. Patrick Hubbard,
Sophisticated Robots: Balancing Liability, Regulation, and Innovation, 66
FLA. L. REV. 1803, 1839 (2014) (noting even cases brought by workers injured
by robots on the job . . . have generally been unsuccessful; making no mention
of any case ever brought by an injured consumer of a robot-built product).
195. RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 5 cmt. c (rejecting
strict liability duties that would require the seller to develop expertise
regarding a multitude of different end products and to investigate the actual
use of raw materials and stating [c]ourts uniformly refuse to impose such an
onerous duty).
196. Henderson, supra note 107, at 117071 (footnotes omitted).
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manufacturing to design in complexity may result in more
effective safety devices:
Imagine products that could continue a post-sale conversation:
products that could report back to . . . the manufacturer about its
identification, its maintenance schedule, its lifecycle, even after a
loss or injury? With the opportunity to embed devices inside of
products as they are being built . . . imagine having the capability to
avoid safety devices being disabled or circumvented and products
that could record lifecycle events to anticipate and avoid product
failure.197
As 3D printing continues to disrupt traditional
manufacturing, products liability law will undoubtedly evolve
to accommodate the new technology.
IV. 3D PRINTING AND ITS IMPACT ON MEDICAL DEVICE
AND HEALTH CARE
3D printing will impact health care in many ways,
including implantable and non-implantable medical devices, as
well as cost-effective patient-matched devices.198 To the novel
products liability issues raised by 3D printing generally,
prescription medical devices and drugs add the overlay and
interplay of U.S. Food and Drug Administration (FDA)
regulation.199 Already, the FDA has cleared over 80 medical
devices that are 3D-printed,200 and approved one prescription
drug in which the pill is 3D-printed with numerous voids and
layers to increase its rate of dissolution.201
One of the most exciting prospects and radical ways that
3D printing is shaping the medical industry is bioprinting: the
197. Comerford & Belt, supra note 16, at 833.
198. Drew Hendricks, 3D Printing is Already Changing Health Care,
HARV. BUS. REV. (Mar. 4, 2016), https://hbr.org/2016/03/3d-printing-is-already-
changing-health-care.
199. 3D-printed food also implicates FDA regulations, including labeling
issues. See Tran, supra note 11, at 87176.
200. Urs Widmer & Ramiro Dip, 3D Printing in MedicineImplications for
Insurance, SWISS RE, RISK DIALOGUE MAGAZINE (Apr. 18, 2016), http://cgd
.swissre.com/risk_dialogue_magazine/3D_printing/3D_Printing_in_Medicine
_Implications_for_Insurance.html (FDA has already approved 85 3D printed
medical devices.).
201. The drug SPRITAM uses three-dimensional printing (3DP) to
produce a porous formulation that rapidly disintegrates with a sip of liquid.
Press Release, Aprecia, FDA Approves the First 3D Printed Drug
(Aug. 3, 2015), http://www.multivu.com/players/English/7577251-aprecia-
pharmaceuticals-spritam/. See also infra note 236 and accompanying text.
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3D printing of human tissues by depositing cells layer-by-layer
to grow organs.202 Should the promise become fully realized,
the ability to print organs on demand will mean more lives will
be saved, particularly those of patients currently waiting on
lists and in desperate need of organ transplants.203 Gone will be
the day when immunosuppressants are needed to prevent
rejection of transplanted organs, because the organs will be
printed using the patients own stem cells.204 Patients will be
able to receive the organ they need, when they need it, and one
that is customized to their body.205
Developments in this area are progressing rapidly. In
March 2011, Anthony Atala, director of the Wake Forest
Institute for Regenerative Medicine, gave a TED talk regarding
the future of bioprinting and held in his hands a 3D-printed
kidney prototype.206 Four years later, a company announced
the first 3D-printed human kidney tissue, a key development
toward the treatment of kidney diseases and one step closer to
making printing implantable kidneys a reality.207
In addition, 3D printing of tissues has the potential to
reduce the need for experimentation and testing of drugs,
cosmetics, and medical devices on animals.208
202. Anthony Atala, Printing a Human Kidney, TED (Mar. 2011), https://
www.ted.com/talks/anthony_atala_printing_a_human_kidney (discussing, in a
video, the possibilities and challenges of 3D printing solid organs).
203. Id.
204. BARNATT, supra note 33, at 19. This also will blur the regulatory line
between medical devices and biologics.
205. See Atala, supra note 202 (demonstrating the success of a bladder that
was crafted using scaffolding and tissues from the patient).
206. Id.
207. Michael Molitch-Hou, Organovo Announces Its First 3D Bioprinted
Kidney Tissue, 3D PRINTING INDUSTRY (Apr. 1, 2015), http://
3dprintingindustry.com/2015/04/01/organovo-announces-its-first-3d-bioprinted
-kidney-tissue/. This breakthrough is significant because the tissue is a
combination of four types of kidney cells as opposed to previous printed organs
that relied on a single layer cell cultures.
208. Vaibhav Bagaria & Lopaa Bagaria, 3D Printing Revolutionizing
Healthcare, EHEALTH (Jan. 14, 2015), http://ehealth.eletsonline.com/2015/01
/3d-printing-revolutionizing-healthcare/ (explaining how 3D-printed tissues
can help prepare surgeons for their operations); see Adele Peters, 3-D Printing
Cells for Drug Testing Could Keep Animals out of Harms Way, FAST CO.:
CO.EXIST (Jan. 27, 2014), http://www.fastcoexist.com/3021871/3-d-printing-
cells-for-drug-testing-could-keep-animals-out-of-harms-way (explaining that
nine out of ten drugs tested on animals fail at the human testing stage and
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3D printing holds promise for improving health care in
other ways as well. In addition to patient-matched 3D-printed
medical devices, physicians now can use 3D-printed models of a
particular patients organ or body part to better plan out and
practice for complex surgeries, and thus reduce surgical risks,
times, and costs, thereby improving outcomes.209 Whether a
complicated heart surgery or an attempt at facial
reconstruction, the longer the patients internal tissue is
exposed during surgery, the greater the risk of tissue
damage.210
But 3D-printed cells, tissues and organs, and 3D-printed
medical models, are only two types of examples of 3D-printed
objects that are, or could be, used to improve health care and
outcomes for patients. Custom, patient-matched, 3D-printed
medical devices are another, more mature, use of this
technology. For example, prosthetic limbs are now being made
to mirror the size and shape of the patients corresponding limb
through 3D scanning technology.211 An image is first taken of
the patients sound-side limb and existing prosthetic. The
image of the sound-side limb is then laid over the former image
to create a design for the fairing that is then 3D-printed and
fitted to the patient, restoring symmetry to the patients body
and resulting in increased function, comfort, and mobility.212
3D-printed casts are also being used, which help with healing
that using a human on a chip model could be a more efficient way to test
drugs); Belgium Doctors Use Paper-Based 3D Printing to Reduce Surgical
Times, MCOR, http://mcortechnologies.com/doctors-in-belgium-use-mcor-paper-
based-3d-printing-to-dramatically-reduce-surgical-time/ (last visited Oct. 17,
2016) (stating that surgeons in Belgium use printed materials as proxy for a
patients bone structure to reduce the time consuming adjustments during
surgery).
209. See Bagaria & Bagaria, supra note 208.
210. Cf. id. (stating that a reduction in surgery time correlates to a
decrease in blood loss and more favorable post op outcomes).
211. See TJ McCue, 3D Printed Prosthetics, FORBES (Aug. 31, 2014),
http://www.forbes.com/sites/tjmccue/2014/08/31/3d-printed-prosthetics
/#5a74afa3543e (discussing how different groups are utilizing 3D printing and
open source designs to assist in making custom and cost-friendly usable
prosthetics).
212. Cf. Andrei Vakulenko, 3D Scanning Improves Prosthetic Design, MDT
(Dec. 5, 2014), https://www.mdtmag.com/article/2014/12/3d-scanning-improves
-prosthetic-design (discussing and explaining how 3D scanning can be utilized
to improve prostheses).
182 MINN. J.L. SCI. & TECH. [Vol. 18:1
times are able to be patient-matched.213 Some such uses are no
longer investigational.214
A. 3D-PRINTEDMEDICAL DEVICES CURRENTLY BEING
MARKETED.
To date, the FDA has granted clearance through the 510(k)
process for several 3D-printed medical devices, some
implantable. These include hearing aids,215 dental crowns,216
bone tether plates,217 skull plates,218 hip cups,219 spinal
cages,220 knee trays,221 facial implants,222 screws,223 surgical
instruments,224 and Invisalign braces.225
213. See Hendricks supra note 198.
214.
As Brian Proffitt suggests, [v]ery soon . . . the day will come when a
patient in need of a custom medical device, such as a prosthesis or
stent, can have such an object manufactured within minutes right at
the healthcare facility, instead of waiting for days to get the device
delivered from a factory.
Thierer & Marcus, supra note 24, at 840 (quoting Brian Proffitt, How Well
3D-Print the Internet of Things, READWRITE (Oct. 2, 2013), http://readwrite
.com/2013/10/02/3d-printing-internet-of-things/).
215. E.g., Hearing Aid, ENVISIONTEC, http://envisiontec.com/hearing-aid-
industry/ (last visited May 8, 2015).
216. See Dental Industry, ENVISIONTEC, http://envisiontec.com/dental-
industry (last visited Oct. 17, 2016).
217. Letter from Mark N. Melkerson, Dir. Div. of Orthopedic Devices, Dept
of Health & Human Servs., to Jeremy Blair, Project Manager, MedShape, Inc.
(Dec. 18, 2014), http://www.accessdata.fda.gov/cdrh_docs/pdf14/K141420.pdf;
see also Andrew Wheeler, MedShape Inc. Receives FDA Clearance for 3D
Printed Titanium Medical Device, 3D PRINTING INDUSTRY (Feb. 3, 2015),
http://3dprintingindustry.com/2015/02/03/medshape-inc-receives-fda-clearance
-3d-printed-titanium-medical-device/ (discussing the approval of a device used
to correct bunions by tethering two bones together in the foot).
218. Letter from Kesia Y. Alexander writing for Victor Krauthamer, Acting
Dir. Div. of Neurological & Physical Med. Devices, Dept of Health & Human
Servs., to Leigh Ayres, Dir. of Sci. & Regulatory Affairs, Oxford Performance
Materials, LLC (Feb. 26, 2013), http://www.accessdata.fda.gov/cdrh_docs
/pdf12/K121818.pdf.
219. Letter from Lori A. Wiggins writing for Mark N. Melkerson, Dir. Div.
of Orthopedic Devices, Dept of Health & Human Servs., to Sharyn Orton,
Senior Consultant, MEDIcept, Inc. (Nov. 4, 2014), https://www.accessdata.fda
.gov/cdrh_docs/pdf14/K141676.pdf.
220. Letter from Mark N. Melkerson, Dir. Div. of Orthopedic Devices.,
Dept of Health & Human Servs., to Rich Jansen, President, Silver Pine
Consulting, LLC. (Feb. 6, 2015), http://www.accessdata.fda.gov/cdrh_docs
/pdf14/K143126.pdf.
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Some of theselike Invisalign bracesare 3D-printed at a
central facility and then shipped to the prescribing health care
provider,226 reflecting a more traditional distribution system.
However, the non-traditional devolution of the manufacturing
functioni.e., point-of-care manufacturingthat 3D printing
promises has also made its way to the medical device sphere.227
Either way, by using 3D printing, these devices can be easily
and rapidly customized for each patient.228
After digitally scanning the area to be operated on,
surgeons can print 3D models to scalesometimes with mixed
colors and media to reflect different structuresto map out the
221. Letter from Erin I. Keith, writing for Mark N. Melkerson, Dir. Div. of
Orthopedic Devices, Dept of Health & Human Servs., to Kevin Thomas,
PaxMed Intl, LLC (Feb. 14, 2013), http://www.accessdata.fda.gov/cdrh_docs
/pdf12/K120038.pdf.
222. Letter from David Krause writing for Binita S. Ashar, Dir. Div. of
Surgical Devices, Dept of Health & Human Servs., to Leigh Ayres, Dir. of Sci.
& Regulatory Affairs, Oxford Performance Materials, Inc. (July 28, 2014),
http://www.accessdata.fda.gov/cdrh_docs/pdf13/K133809.pdf.
223. Letter from Mark. N. Melkerson, Dir. Div of Surgical, Orthopedic &
Restorative Devices, Dept of Health & Human Servs., to J.D. Webb, Renovis
Surgical Techs., LLC. (May 15, 2012), http://www.accessdata.fda.gov/cdrh
_docs/pdf11/K111940.pdf.
224. Letter from David Krause writing for Binita S. Ashar, Dir. Div. of
Surgical Devices, Dept of Health & Human Servs., to Oliver Clemens,
Materialise N.V. (Apr. 10, 2014), http://www.accessdata.fda.gov/cdrh_docs
/pdf13/K132290.pdf.
225. Letter from Chiu S. Lin, Dir. Div. of Anesthesiology, Gen. Hosp.,
Infection Control & Dental Devices, Dept of Health & Human Servs., to
Sangeeta Sachdeva, Manager of Regulatory Affairs, Align Tech. Inc.,
(Dec. 17, 2008), https://www.accessdata.fda.gov/cdrh_docs/pdf8/K081960.pdf.
See generally Ventola, supra note 4, at 708 (explaining that 50,000 Invisalign
braces are printed every day).
226. See generally ALIGN TECH. INC., 2015 ANNUAL REPORT 1, 45 (2016),
http://files.shareholder.com/downloads/ALGN/2902946222x0x883123/D8C40A
25-8897-42D8-A655-1158ED4D032F/2015_Annual_Report.pdf.
227. See generally TJ McCue, supra note 211; Widmer & Dip, supra note
200 ([A]s technology enables new applications, it is conceivable that 3D
manufacturing will have to take place closer to the patient, which would
complicate the chain of parties involved in the process, and lead to potentially
overlapping liability responsibilities and the associated regulatory
challenges.).
228. McCue, supra note 211; Bagaria & Bagaria, supra note 208.
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planned procedure or to confirm that implants will fit as
expected.229
Describing some of the relatively new companies leading
the way in innovation of 3D-printed medical devices provides
just a glimpse of the possibilities that exist:
 Clear Correct, LLC uses 3D printers to manufacture
clear plastic braces. First, a patients teeth are scanned
and then a computer model of the patients teeth is
created, showing the teeths current alignment and desired
alignment. Next, a 3D printer is used to create a series of
models of the teeth, which represent a progression of the
teeths current alignment to a straight alignment.
Traditional manufacturing techniques can then be used to
create the aligners. The aligners and 3D-printed models
are then sent to the patients dentist, who can utilize the
3D-printed model to assist the dentist in fitting the patient
with the appropriate aligners.230
 MedShape, Inc. develops and commercializes
orthopedic devices using proprietary shape memory
technology. The FDA granted 510(k) clearance to
MedShapes Class II implantable medical device, the
FastForward Bone Tether Plate, which is created through
the 3D printing of medical grade titanium alloy, which
allows fabrication of devices with complex and
customizable geometries. The plate serves as the primary
component in the FastForward Bunion Correction System,
a new approach for surgical correction of hallux valgus
deformities that preserves and protects the native bone
anatomy (510(k) Number: K141420). 231
 Oxford Performance Materials (OPM) received
510(k) clearance for its 3D-printed OsteoFab Patient-
Specific Facial Device, the first and only FDA-cleared 3D-
printed polymeric implant for facial indications, and
follows FDA clearance of the first and only 3D-printed
229. See SNYDER ET AL., supra note 24, at 10. See generally Joris Peels,
From Medical Scan to 3D Print for Medical Applications, LUXEXCEL
(Jan. 6, 2016, 9:00 AM), http://blog.luxexcel.com/from-medical-scan-to-3d-
print-medical-applications.
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polymeric implant, OPMs OsteoFab Patient-Specific
Cranial Device, which was granted in February 2013.232
Both products are Class II medical devices (510(k)
Numbers: K133809 and K121818).
 Renovis Surgical Technologies, Inc. supplies
orthopedic implants to surgeons and hospitals for adult
spinal joint reconstruction, and trauma surgery
applications. Renovis received 510(k) clearance for
its Tesera Stand-alone ALIF Cage, a titanium implant that
uses additive manufacturing to create porous surfaces that
aid bone in-growth from the vertebral endplates.233 (510(k)
Number: K132312).
These are only a few of the companies that are now using
additive manufacturing technology to create medical devices.234
Each of these companies receives patient specifications (often
through a scanned image sent in by a physician or dentist) and
prints the medical device to those specifications.235 Printing the
devices at a central facility allows these companies to regulate
quality, biocompatibility of materials, and sterility, and in
many ways is only slightly different from how medical device
230. ClearCorrect Expands Its Fleet of Stratasys Dental 3D Printers,
Increasing Production Capacity by 30 Percent, BUSINESS WIRE (May 12, 2015,
2:00 AM), http://www.businesswire.com/news/home/20150511005035/en
/ClearCorrect-Expands-Fleet-Stratasys-Dental-3D-Printers.
231. SeeWheeler, supra note 217.
232. Press Release, OPM, OPM Receives FDA Clearance for 3D Printed
OsteoFab Patient-Specific Facial Device (Aug. 19, 2014), http://www.oxfordpm
.com/opm-receives-fda-clearance-3d-printed-osteofab-patient-specific-facial-
device; see alsoMichael Molitch-Hou, The First 3D Printed Polymer Implant to
Receive FDA Approval, 3D PRINTING INDUSTRY (Feb. 22, 2013), http://
3dprintingindustry.com/2013/02/22/the-first-3d-printed-polymer-implant-to-
receive-fda-approval/.
233. Press Release, Renovis, Renovis Surgical Received FDA Clearance of
Porous Titanium Spinal Implant (Oct. 3, 2013), http://www.renovis-surgical
.com/2013/10/renovis-surgical-received-fda-clearance-of-porous-titanium-
spinal-implant/.
234. See, e.g., Top 10 3D Bioprinting Companies, TECHNAVIO (Sept. 4,
2014), http://www.technavio.com/blog/top-10-3d-bioprinting-companies (listing
ten companies utilizing 3D printing for bioprinting).
235. See ClearCorrect Expands Its Fleet of Stratasys Dental 3D Printers,
Increasing Production Capacity by 30 Percent, supra note 230; Wheeler, supra
note 217; Molitch-Hou, supra note 232; Press Release, supra note 233.
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manufacturers traditionally have produced their products, with
the main difference being cost.
As to pharmaceutical drugs, Aprecia Pharmaceuticals
Company announced that the FDA granted approval for the
first ever 3D-printed drug tablet for use in the treatment of
epilepsy.236 Aprecias proprietary 3D printing technology allows
it to make porous tablets that rapidly disintegrate when taken
with water, thereby aiding patients who struggle to take large,
hard-to-swallow medications.237
As the technology develops further and 3D printers become
ever more accessible, increased migration of the manufacturing
function toward on-site printing is inevitable. This migration of
manufacturing to non-traditional and dispersed locations will
undoubtedly present numerous additional legal complications.
B. THE FDAS APPROACH TO 3D PRINTING
Drug and medical device manufacturers are already
incorporating 3D printing into marketing applications for
review by the FDA.238 So far, this approach is working, and it
may largely be because the FDA views 3D printing/additive
manufacturing as another form of advanced manufacturing.239
As such, the FDA makes a benefit-risk determination of such
products incorporating advanced manufacturing, like 3D
236. See Press Release, Aprecia Pharmaceuticals, First FDA-Approved
Medicine Manufactured Using 3D Printing Technology Now Available (Mar.
22, 2016), https://www.aprecia.com/pdf/ApreciaSPRITAMLaunchPressRelease
__FINAL.PDF.
237. See 3D Printing, APRECIA PHARMACEUTICALS, https://www.aprecia
.com/zipdose-platform/3d-printing.php (last visited Oct. 18, 2016); see also
Jennifer Hicks, FDA Approved 3D Printed Drug Available in the US, FORBES
(Mar. 22, 2016), http://www.forbes.com/sites/jenniferhicks/2016/03/22/fda-
approved-3d-printed-drug-available-in-the-us/#7422481113d0. Test runs of the
drug are currently being run. Ann Thompson, Blue Ash Pharma Company
Launches 3D Printed Pill, WVXU (Mar. 28, 2016), http://wvxu.org/post/blue-
ash-pharma-company-launches-3d-printed-pill.
238. See Dhruv Bhate, 3-D Printing Applications Changing Healthcare,
DEVICETALK (Mar. 11, 2016), http://www.mddionline.com/blog/devicetalk/3-d-
printing-applications-changing-healthcare-03-11-16 (describing drugs and
devices).
239. See Jamie Hartford, FDAs View on 3-D Printing Medical Devices,
MED. DEVICE & DIAGNOSTIC INDUSTRY (Feb. 11, 2015), http://www.mddionline
.com/article/fdas-view-3-d-printing-medical-devices (discussing FDAs director
of the Office of Science and Engineering Laboratories, Stephen Pollacks,
speech to his audience at the medical device conference at MD&M West).
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printing, as well as an evaluation for safety and effectiveness of
the products.240 As discussed, the FDA has allowed one 3D-
printed drug and scores of 3D-printed medical devices to be
marketed.241 Almost all 3D-printed medical devices are on the
market as substantially equivalent, under Federal Food,
Drug, and Cosmetic Acts (FDCA) § 510k,242 to already
marketed products, so the FDAs current position appears to be
that the end result, not the utilization of a novel production
process, is what matters.243
Under the 510(k) pathway, applicants must demonstrate
that their device is at least as safe and effective as, that is,
substantially equivalent to, a legally marketed, or predicate,
device.244 Essentially, applicants must compare their device
with one or more existing commercial devices, and provide data
to support the claim of substantial equivalence. If the FDA
agrees, the product is cleared for commercial use.245
Importantly, a proposed 510(k) device must not be classified as
a high-risk product (i.e., Class III) requiring Pre-Market
Approval (PMA).246 Such high-risk products will require the
FDAs scientific and regulatory review of the full complement of
scientific evidence to support a finding that the product is safe
and effective.247 If such safety and efficacy is demonstrated, the
product is approved.248 The FDA has not yet approved any
240. Cf. id. (stating that the FDA makes a determination of 3D-printed
products in the same manner as other advanced manufacturing methods, and
stating that some concerns with 3D-printed devices includes safety,
compatibility, usability, and cleanliness).
241. See, e.g., Bhate, supra note 238; Maya M. Eckstein & Kyle Sampson,
How Will the FDA Regulate 3D Printing?, INSIDE COUNSEL (Mar. 9, 2016),
http://www.insidecounsel.com/2016/03/09/how-will-the-fda-regulate-3d-
printing (describing devices); see also infra note 200 and accompanying text.
242. 21 U.S.C. § 360c(i) (2012).
243. Widmer & Dip, supra note 200 (FDA does not seem to be as perplexed
by additive manufacturing as it was feared. After all, 3D printing is just a
manufacturing technology, an enabling technology, not something completely
unusual that has not been seen before.).
244. See 21 U.S.C. § 360c(i)(1)(A).
245. See, e.g., Letter from Lori A. Wiggins writing for Mark N. Melkerson,
supra note 219.
246. See 21 C.F.R. § 807.81 (2016).
247. See id. § 807.87.
248. Hartford, supra note 239.
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PMAs for 3D-printed medical devices.249 This is likely because
the development of truly innovative medical devices using 3D
printing technology is still underway. According to the director
of the FDAs Office of Science and Engineering Laboratories
(OSEL), the FDA is still waiting for devices that we havent
been able to make before, and thats when were going to see
the PMAs.250 Thus, the products that incorporate 3D
technology so far are not new and innovative per se. Rather,
they are products of a type already in use, albeit developed
with 3D printing technology, where the benefit may be that the
devices are customizable to the needs of the patient.
The FDA has created two laboratories within the OSEL
that are studying the future potential effects of 3D technology
on medical device manufacturingthe FDAs Laboratory for
Solid Mechanics and the FDAs Functional Performance and
Device Use Laboratory.251 The FDAs Laboratory for Solid
Mechanics is studying the effect of different printing
techniques and processes on the durability and strength of
various medical device materials.252 This research is
anticipated to help inform the development of standards and
establish parameters for scale, materials, and other critical
aspects that contribute to product safety and innovation.253
The Functional Performance and Device Use Laboratory is
working on computer-modeling methods.254 The focus of its
research is to help the FDA understand how changes to the
design of medical devices potentially impact safety and
performance in differing patient populations.255 These
computer-modeling methods allow the FDA to research
changes in a device design, and then evaluate the effect of
those changes.256
249. Id. (Were still waiting for devices that we havent been able to make
before, and thats when were going to see the PMAs.) (quoting Steven K.
Pollack, Director of the FDAs Office of Science and Engineering Laboratories).
250. Id.
251. James Coburn, FDA Research into 3D Printing of its Regulated
Products, FOOD & DRUG ADMIN. (July 14, 2016), https://collaboration.fda.gov
/p8vdqep00c8/?launcher=false&fcsContent=true&pbMode=normal.
252. Id.
253. Id.
254. Id.
255. Id.
256. Id.
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In order to get a full understanding of the technology, on
October 8 and 9, 2014, the FDA held a workshop at its White
Oak Campus in Silver Spring, Maryland, to obtain information
and input about 3D printing issues.257 The FDA brought
together technical 3D printing expertise from various
industries spanning medical to aviation application, to help the
agency understand the technical assessments that should be
considered for 3D-printed devices as part of a transparent
evaluation process for future submissions of novel and unique
medical devices resulting from additive manufacturing
techniques.258 Workshop attendees included medical device
manufacturers, additive manufacturing companies, academia,
and researchers, scientists, and engineers involved with the
research and development of 3D-printed products.259 The FDAs
2014 public workshop on 3D printing,260 and accompanying
request for comment on aspects of [additive manufacturing]
that are important to medical device quality, safety, and
effectiveness261 raised hopes that guidance might be
forthcoming.
In May 2016, that guidance came when the FDA released a
draft guidance for Technical Considerations for Additive
Manufactured Devices.262
The draft guidance sets forth technical assessments that
manufacturers of certain 3D-printed medical devices should
257. See Public Workshop-Additive Manufacturing of Medical Devices: An
Interactive Discussion on the Technical Considerations of 3D Printing,
FDA.GOV (last visited Oct. 19, 2016), http://www.fda.gov/MedicalDevices
/NewsEvents/WorkshopsConferences/ucm397324.htm.
258. See id.
259. See id.
260. See id.; Guidance Agenda, Food & Drug Admin., New and Revised
Draft Guidances CDER is Planning to Publish During Calendar Year 2016
(Aug. 8, 2016), http://www.fda.gov/downloads/drugs/guidancecompliance
regulatoryinformation/guidances/ucm417290.pdf.
261. See Questions Prepared for and Derived from the FDA Additive
Manufacturing Workshop, FDA.GOV, http://www.fda.gov/downloads/Medical
Devices/NewsEvents/WorkshopsConferences/UCM421656.pdf (last visited Oct.
19, 2016).
262. FOOD & DRUG ADMIN., TECHNICAL CONSIDERATIONS FOR ADDITIVE
MANUFACTURED DEVICES: DRAFT GUIDANCE FOR INDUSTRY AND FOOD & DRUG
ADMINISTRATION STAFF (2016), http://www.fda.gov/downloads/medicaldevices
/deviceregulationandguidance/guidancedocuments/ucm499809.pdf.
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consider.263 The FDAs draft guidance is meant to provide a
transparent evaluation process for future submissions.264
According to the FDA, the draft guidance is a leap-frog
guidance to share the FDAs initial thoughts regarding
emerging technologies that are likely to be of public health
importance early in product development.265 It is not meant to
be a comprehensive document addressing all regulatory
requirements; but it does highlight the technical considerations
and makes recommendations for the design, manufacturing,
and testing of medical devices that include at least one
fabrication step using additive manufacturing.266
The draft guidance is based, in part, on the feedback from
the October workshop.267 It also likely reflects the experience
and knowledge of the FDAs OSEL employees, as well as the
recent experience gained by the agency while reviewing and
clearing or approving applications for scores of medical devices
and one prescription drug that are produced by 3D printing
techniques.268
The draft guidance is split between two main areas of
focus: (1) design and manufacturing and (2) device testing.269
Both sections overlap in substance, and the device testing
section in particular provides strong, detailed
recommendations for what a device manufacturer should
include in a premarket submission for a device that uses
additive manufacturing.270
The following recommendations in the draft guidance will
likely have an effect on how 3D printing device companies
design, manufacture, and test their devices, especially those
who manufacture patient-matched devices (devices that are
customized for a specific patients anatomy, usually based on
medical imaging data), to which the FDA draft guidance pays
particular attention.271
263. See id. at 1.
264. See id.
265. See id. at 2.
266. See id. at 12.
267. See id. at 34.
268. Id. at 3.
269. See id. at 1.
270. See generally id.
271. See id. at 8.
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Design and Manufacturing Considerations. The
FDAs recommendations for design and manufacturing
considerations are likely not as useful, as many sound
platitudinous. These include:
 That manufacturing and dimensional specifications be
carefully considered and documented.272
 For patient-matched devices, understanding the image
quality and the role deformation may play.273 Also
ensuring that the label expiration date account for time-
dependent changes to the patient anatomy before the
device is used.274
 Any software used to make patient-matched
modifications to a devices design should include internal
checks that prevent the user from exceeding the pre-
established device specifications documented in the device
master record.275
 All software file conversation steps should be tested in
worst-case scenarios.276
 Before a device is additively manufactured,
considerations should be made for build volume
placements, use of support material, layer thickness, build
paths, machine parameters, and environmental
considerations.277
 Understanding the chemical properties of the material
being used and how the additive manufacturing process
may affect those properties.278
 Process validation and consistency of quality are key. In
other words, knowledge of how the variability of each
272. See id. at 2122.
273. See id. at 89.
274. Id. at 9.
275. See id. at 910.
276. Id. at 10.
277. See id. at 1314.
278. See id. at 1415.
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input parameter and processing step affects the final
finished device or component is critical to ensuring party
quality.279
Device Testing Considerations. For device testing
considerations, the FDA recommends that the following (if
applicable for the particular device) be included in a premarket
submission for a medical device using 3D printing:280
 Range of dimensions for the device (small, medium,
large) and any dimensions that may be altered to match a
patients anatomy.281
 Performance testing results. While these are generally
the same for any device, whether 3D-printed or
traditionally manufactured, for 3D-printed devices build
direction orientation should be considered when testing is
performed.282
 Dimensional tolerances and measurements should be
specified.283
 All materials involved in the manufacturing of the
medical device should be clearly identified.284
 Material polymers may need to be tested to ensure that
they will not unintentionally form chemical properties
through the additive manufacturing process, which may
pose a risk to patient health.285
 Interlayer bonding materials should be characterized.286
 Any cleaning and sterilization process for a final
product should be validated and should consider the
279. See id. at 16.
280. See id. at 19.
281. See id. at 1920.
282. See id. at 2021.
283. See id. at 2122.
284. See id. at 22.
285. See id.
286. See id. at 2223.
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complex geometry of the final product.287 Only additive
manufactured devices that were cleaned of manufacturing
materials should be provided to the end user.288
 The biocompatibility of the final device should be
evaluated.289
 Additional labeling considerations for patient-matched
devices is recommended to include the patient identifier,
identifying use, file design iteration, and that the patient
be surveyed for potential anatomical changes (between the
time of imaging and surgery).290
The FDA has plainly put a lot of time into thinking about
the unique technical aspects involved in 3D printing of medical
devices and ensuring that the manufacturers of those devices
consider these issues when submitting a premarket
application. The FDA understands that 3D printing has
numerous advantages for medical devices, but at the same time
poses significant challenges.291 While the draft guidance is a
necessary step in the right direction and resolves some
questions, many issues still remain unclear.
In general, the draft guidance does not change the current
regulatory pathway to market for medical devices, whether 3D-
printed or traditionally manufactured. Manufacturers who use
additive technology in their medical devices will continue to use
traditional pathways. This is no different than how the FDA
has handled the already more than 80 medical devices cleared
by the FDA to date.
The draft guidance, however, does pay particular attention
to the unique technical considerations involved in 3D printing,
generally, and how those procedural issues should be assessed
and documented in premarket submissions. The draft guidance
is helpful in the sense that it outlines what the FDA is looking
for in premarket submissions for 3D-printed medical devices,
287. See id. at 2325.
288. See id.
289. See id. at 25.
290. See id.
291. See generally id.
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and also how the FDA considers such products in its regulatory
frameworkbasically the same as any other medical device.292
The draft guidance also pays particular attention to
patient-matched-devices, which are one of the numerous
applications of 3D printing in healthcare, because this type of
personalized medicine helps deliver the right device, that is the
right size, to the right patient. While these devices are
considered custom in the 3D printing industry, the draft
guidance clarifies that patient-matched-devices do not fall into
the FDCAs custom device exemption under section 520(b)(2).293
Under section 520(b)(2), the FDCA exempts certain generic
medical device types (i.e., a grouping of devices that do not
differ significantly in purpose, design, materials, energy source,
function, or any other feature related to safety and
effectiveness) from some, but not all, FDA regulatory
oversight.294 For instance, although manufacturers do not need
to seek premarket approval or conform to mandatory
performance standards, they still need to comply with the
FDAs Quality System Regulation (QS) requirements and
standards.295 Medical devices falling within this custom device
exemption must be made to the specifications of a single
patient based on their prescribed needs as determined by a
healthcare professional, and must not be generally available in
the United States in finished form.296 Notably, the exemption is
available only when less than five of custom device types are
manufactured per year.297 Thus, assuming a 3D-printed
medical device could qualify for the threshold criteria for the
FDCA exemption, the statutory limit of no more than five
292. See generally id.
293. See id. at 8.
294. See 21 U.S.C. §§ 360c(i), 360j (2012).
295. Current Good Manufacturing Practice In Manufacturing, Packing, Or
Holding Human Food, 21 C.F.R. § 110 (2016) (illustrating that all of these
requirements may become difficult to control if 3D printing takes place at
decentralized locations, including a hospital or doctors office; there likely
would be no way to have quality control with either the CAD files or the
facility (if not centralized)). These same issues also effect recalls, and the
recalls probably would be limited to 3D printers and centrally manufactured
products or become voluntary.
296. FOOD & DRUG ADMIN., CUSTOM DEVICE EXEMPTION: GUIDANCE FOR
INDUSTRY AND FOOD AND DRUG ADMINISTRATION STAFF 8 (2014).
297. Id. at 3.
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units per year would prohibit any large-scale 3D printing
operations. In the draft guidance, the FDA is clearly sending a
warning (or reminder) to those who mistakenly believe the
exemption might apply broadly to 3D-printed devices.
The FDA also provides that a manufacturer should take
several things into account regarding the unique nature of
patient-matched-devices, such as drafting labeling, making
sure to include the patient identifier, identifying use, file
design iteration, and that the patient is surveyed for potential
anatomical changes (between the time of imaging and
surgery).298
However, the FDA does not provide any guidance on who is
a manufacturer.299 Under the existing FDA regulatory
framework, a manufacturer is defined broadly to include any
person who designs, manufactures, fabricates, assembles, or
processes a finished device.300 As 3D printers become
increasingly accessible, a person (or entity) with a 3D printer
does not require the financial capital, infrastructure or
resources historically associated with traditional
manufacturing operations.301 While the draft guidance
acknowledges point-of-care manufacturing, it does not provide
much discussion on non-traditional entities, such as healthcare
providers and suppliers becoming manufacturers of medical
devices.
The FDA is also careful to warn that the guidance does not
apply to any devices that use bioprintingwhich
incorporat[e] . . . biological, cellular, or tissue-based products
in [the additive manufacturing process].302 These products
have some of the greatest potential to change healthcare, yet
the draft guidance is virtually silent on the regulatory
298. FOOD & DRUG ADMIN., TECHNICAL CONSIDERATIONS FOR ADDITIVE
MANUFACTURED DEVICES: DRAFT GUIDANCE FOR INDUSTRY AND FOOD AND
DRUG ADMINISTRATION STAFF, supra note 262, at 25.
299. See generally id.
300. Definitions, 21 C.F.R. § 820.3(o) (2016).
301. Thierer & Marcus, supra note 24, at 84245 (discussing implications
of decentralizing manufacturing of medical devices and suggesting that the
FDA issue a comprehensive risk education campaign).
302. FOOD & DRUG ADMIN., TECHNICAL CONSIDERATIONS FOR ADDITIVE
MANUFACTURED DEVICES: DRAFT GUIDANCE FOR INDUSTRY AND FOOD AND
DRUG ADMINISTRATION STAFF, supra note 262, at 2.
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framework and impact that such devices will have.303 How the
FDA will ultimately regulate bioprinting remains unclear.304
Investigational and therapeutic use of 3D bioprinters to create
living prostheses and replacement organs is well underway.305
The FDA will probably regulate such material as biologicals,306
and will also likely implicate state blood shield statutes to the
extent that such statutes extend to human tissue generally.307
Combination products are also not mentioned in the draft
guidance.308 These would also include some of the most
innovative and cutting-edge new healthcare products that
combine, in some conjugation or other, drugs, devices and
biologics, whether entirely or partially 3D-printed.
Researchers utilizing 3D printing are doing things today
that only a few years ago were consigned to the realm of science
fiction, such as 3D printing living tissue and cells309 or using
conductive, 3D printable ink, to create proof-of-concept
303. See id. at 2 (Biological, cellular or tissue-based products
manufactured using [additive manufacturing] technology may necessitate
additional regulatory and manufacturing process considerations and/or
different regulatory pathways.).
304. See id. (This draft guidance is . . . intended to serve as a mechanism
by which the Agency can share initial thoughts regarding emerging
technologies that are likely to be of public health importance early in product
development. This . . . guidance represents the Agencys initial thinking, and
our recommendations may change as more information becomes available.).
305. See, e.g., Heidi Ledford, Printed Body Parts Come Alive, 520 NATURE
273 (2015), http://www.nature.com/polopoly_fs/1.17320!/menu/main
/topColumns/topLeftColumn/pdf/520273a.pdf (providing experimental
examples of 3D-printed ear tissue, polymer bones, and titanium hip joints);
Robert J. Szczerba, No Donor Required: 5 Body Parts You Can Make with 3-D
Printers, FORBES (June 17, 2015, 07:57 AM), http://www.forbes.com/sites
/robertszczerba/2015/06/17/no-donor-required-5-body-parts-you-can-make-with
-3-d-printers-2/#33ae3d04a3b4 (listing examples of 3D bioprinting).
306. See generally 21 C.F.R. §§ 601.1680.3 (2016) (subchapter covering
FDA regulation of biologics).
307. See RESTATEMENT (THIRD) OF TORTS: PRODS. LIAB. § 19, reporters
note to cmt. c (AM. LAW INST. 1998) (discussing statutes excluding blood and
other human tissues from the definition of product to address policy concerns,
resulting in limited liability).
308. See generally FOOD & DRUG ADMIN., TECHNICAL CONSIDERATIONS FOR
ADDITIVE MANUFACTURED DEVICES: DRAFT GUIDANCE FOR INDUSTRY AND
FOOD AND DRUG ADMINISTRATION STAFF, supra note 262.
309. See supra note 305 and accompanying text.
2017] 3D PRINTING & PRODUCTS LIABILITY 197
biomedical products.310 Although further research is needed
before these concepts evolve into viable commercial
applications for the use in the healthcare industry, it is likely
not too far away.311 How the FDA will approach these and
other innovative products remains unknown.312
The draft guidance will undoubtedly assist 3D printing
device companies in designing, manufacturing, and testing
their devices, especially those who manufacture patient-
matched-devices.313 It provides a baseline framework for 3D
printing that will help many in the industry prepare for
engaging the FDA early in product development.314
Eventually, however, the FDA should issue current good
manufacturing practice guidance specifically concerning
additive manufacturing, and the FDA will have to determine
whether on-site 3D printing of medical devices in hospitals and
doctors offices constitutes device manufacturing that requires
310. Adam E. Jakus et al., Three-Dimensional Printing of High-Content
Graphene Scaffolds for Electronic and Biomedical Applications, 9 ACS NANO
4636, 4336 (2015); see also 3D Printing of Conductive Metallic Inks Could Lead
to Customized Electronics, Biomedical Devices, AZO MATERIALS (May 18,
2016, 4:52 AM), http://www.azom.com/news.aspx?newsID=45661 (speculating
on application of 3D printing of conductive material).
311. Cf. supra notes 305, 310 and accompanying text (demonstrating active
development of field).
312. See supra notes 30204 and accompanying text.
313. See FOOD & DRUG ADMIN., TECHNICAL CONSIDERATIONS FOR
ADDITIVE MANUFACTURED DEVICES: DRAFT GUIDANCE FOR INDUSTRY AND
FOOD AND DRUG ADMINISTRATION STAFF, supra note 262, at 12 (The
purpose of this guidance is to outline technical considerations associated with
[additive manufacturing] processes, and recommendations for testing and
characterization for devices that include at least one [additive manufacturing]
fabrication step . . . . The Device Testing Considerations section describes the
type of information that should be provided in premarket notification
submissions . . . premarket approval (PMA) applications, humanitarian device
exemption (HDE) applications, de novo requests and investigational device
exemption (IDE) applications for an [additive manufacturing] device.)
(emphasis added).
314. Id. at 1 (FDA has developed this draft guidance to provide FDAs
initial thinking on technical considerations specific to devices using additive
manufacturing, the broad category of manufacturing encompassing 3-
dimensional (3D) printing . . . . [G]uidances describe the Agencys current
thinking on a topic and should be viewed only as recommendations, unless
specific regulatory or statutory requirements are cited.).
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compliance with the FDAs panoply of regulations governing
such entities.315
V. PRODUCTS LIABILITY CONSIDERATIONS SPECIFIC
TO 3D-PRINTED DRUGS AND MEDICAL DEVICES
While the FDA is beginning to work out the regulatory
issues with 3D printing of medical devices, many products
liability implications of such devices also exist. The common
law, so far, does not consider electronic data such as CAD files
used in 3D printing to be products,316 thus the FDA could
conceivably treat them as labeling, since the definition is very
broad.317 In that case, the FDA could require CAD files to
include the same warnings and other information that must
accompany the physical device, and CAD files without such
information labeling could be considered misbranded.318
As long as 3D printers used to create medical devices
remain in the hands of traditional manufacturers, those
manufacturers and their products will still be subject to
traditional products liability litigation.319 However, in a
number of instances the location of the printer, and thus what
was traditionally considered manufacturing, is elsewhere
particularly point-of-care manufacturing at hospitals and/or
physicians offices.320 It is possible that the FDA could consider
315. The FDA continues to be committed to 3D printing holding a
presentation that provide[d] a snapshot of ongoing research efforts internally
and in collaboration with FDAs academic partners. The topics of the
presentation included phantoms for device testing, patient-matched devices
instrumentation, cleanability assessment, material optimization, and drug
printing optimization. See Webcast: James Coburn, FDA Research into 3D
Printing of Its Regulated Products, FOOD & DRUG ADMIN. (July 14, 2016, 12:00
PM), https://collaboration.fda.gov/p8vdqep00c8/?launcher=false&fcsCon
tent=true&pbMode=normal (abstract located at http://www.fda.gov/Science
Research/AboutScienceResearchatFDA/ucm515041.htm).
316. See supra notes 10756.
317. Kordel v. United States, 335 U.S. 345, 34750 (1948) (determining
labeling, in regards to misbranded drugs, as meaning all labels and other
written, printed, or graphic matter (1) upon any article or any of its containers
or wrappers, or (2) accompanying such article) (internal quotations omitted).
318. It could be reasoned that CAD documentation supplements or
explains the device, and thus is required labeling. Cf. id. at 349.
319. See supra notes 4081.
320. See supra note 227 and accompanying text.
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these entities to be manufacturers subject to inspection321 and
device-related record-keeping requirements,322 but then use
enforcement discretion to avoid creating excessively onerous
requirements, as it has done so with other internet-based
applications.323
Point-of-care manufacturing by health care providers also
implicates old products liability issues in a new context. First,
many 3D-printed medical devices are, and will be, patient-
matched using electronically inputted data gathered by
computed tomography or magnetic resonance imaging scans. If
other forms of CAD files are considered products,324 then the
same is probably true of these sorts of anatomical scans.
Second, the majority of courtssupplemented in a number
of states by statutory provisionshave traditionally viewed
doctors325 and hospitals326 as service providers, not sellers of
products, as they are neither affiliated with drug or device
321. See 21 U.S.C. § 374(a)(1) (2012) ([The FDA is] authorized (A) to
enter . . . any factory, warehouse, or establishment in which . . . devices . . . are
manufactured, processed, packed, or held . . . and (B) to inspect . . . such
factory, warehouse, or establishment . . . and all pertinent equipment, finished
and unfinished materials, containers, and labeling therein.).
322. Id. § 360i(a) (Every person who is a manufacturer . . . of a device
intended for human use shall establish and maintain such records, make such
reports, and provide such information, as the Secretary may by regulation
reasonably require to assure that such device is not adulterated or
misbranded and to otherwise assure its safety and effectiveness.).
323. See FOOD & DRUG ADMIN., MOBILE MEDICAL APPLICATIONS:
GUIDANCE FOR INDUSTRY AND FOOD AND DRUG ADMINISTRATION STAFF (2015)
(Some mobile apps may meet the definition of a medical device but because
they pose a lower risk to the public, FDA intends to exercise enforcement
discretion over these devices (meaning it will not enforce requirements under
the FD&C Act).).
324. See discussion supra Part III.A.
325. See BECK & VALE, supra note 186, § 8.06[1][a].
326. See id. § 8.05[1]; see, e.g., San Diego Hosp. Assn v. Superior Court, 35
Cal. Rptr. 2d 489, 493 (Cal. Ct. App. 1994) (The hospital is not in the business
of selling or even leasing, bailing or licensing equipment to the physician. It is
in the business of providing medical services to its patients . . . . The fact the
hospital provides equipment for the physicians use is incidental to the
overriding purpose of providing medical services.); Gile v. Kennewick Pub.
Hosp. Dist., 296 P.2d 662, 666 (Wash. 1956) ([T]he contractual relationship
between a hospital and a patient is not one of sale but is one of service; that
during treatment in the hospital [medical products] for which additional
charges are made, may be transferred from the hospital to the patient; and yet
the transfer is an incidental feature of the transaction and not a sale.).
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manufacturers nor marketers in the commercial sphere. The
rationale for rejecting strict products liability is that [t]he
thrust of the inquiry is thus not on whether a separate
consideration is charged for the physical material used in the
exercise of medical skill, but what service is being performed to
restore or maintain the patients health.327 The majority rules
distinction between manufacturing and professional services
will come under pressure as hospitals and doctors offices
incorporate on-site 3D printing centers.328 Hospitals have
already begun using point-of-care manufacturing to create
bespoke anatomical models for individual pre-surgical planning
327. Cafazzo v. Cent. Med. Health Servs., Inc., 668 A.2d 521, 524 (Pa.
1995); see also Hollander v. Sandoz Pharm. Corp., 289 F.3d 1193, 1217, n.22
(10th Cir. 2002) (noting that an overwhelming majority of jurisdictions
decline to subject hospitals to strict products liability); Vergott v. Deseret
Pharm. Co., 463 F.2d 12, 16, n.5 (5th Cir. 1972) (noting a hospital is not a
seller engaged in the business of selling the product under section 402A);
Wages v. Johnson Regl Med. Ctr., 916 F. Supp. 2d 900, 904 (W.D. Ark. 2013)
([H]ospital[s] . . . cannot be considered a products supplier under the
[Arkansas] Products Liability Act simply because the hospital utilizes the
product during a medical procedure.); Samuels v. Health & Hosp. Corp., 432
F. Supp. 1283, 128485 (S.D.N.Y. 1977) ([T]he doctrine of strict liability in
tort is inapplicable to service by the hospital of providing blood transfusions.);
Ayyash v. Henry Ford Health Sys., 533 N.W.2d 353, 356 (Mich. Ct. App. 1995)
(holding that an imposition of strict liability for hospitals would place an
unrealistic burden on the physicians and hospitals of this state to test or
guarantee the tens of thousands of products used in hospitals by doctors.);
San Diego Hosp. Assn, 35 Cal. Rptr. 2d at 493 (holding that a hospital was not
strictly liable for defect in medical device). But see Cunningham v. MacNeal
Meml Hosp., 266 N.E. 2d 897, 904 (Ill. 1970) (allowing a cause of action under
strict tort liability to proceed against a hospital). With respect to the printers
themselves, hospitals and other health care providers should have no greater
liability than for any other item not sold to a patient. See Racer v. Utterman,
629 S.W.2d 387, 398 (Mo. Ct. App. 1981) (declining to extend the definition
and liability of seller to a hospital, whose disposable drapes injured a
patient; finding the hospital in no different position than any other business
which purchases goods for its own use in conducting its business). The
majority rule is not universal, however. See Netherland v. Ethicon, Inc., 813
So. 2d 1254, 1260 (La. Ct. App. 2002) (allowing negligence action against
hospital for distributing allegedly contaminated sutures).
328. In June 2015, Materialise, a Belgian provider of high-end 3D-printed
products, announced that it partnered with Fuwai Hospital in Beijing, China,
to open a medical 3D printing center at the hospital. See Alec Buren,
Materialise & Fuwai Hospital Collaborate on Chinas First Cardiovascular 3D
Printing Center, 3DERS.ORG. (June 25, 2015), http://www.3ders.org/articles
/20150625-materialise-fu-wai-hospital-collaborate-on-china-first-
cardiovascular-3d-printing-center.html.
2017] 3D PRINTING & PRODUCTS LIABILITY 201
based on patient CT scans and MRIs.329 To the extent, however,
that doctors and hospitals operating on-site 3D printers are
concerned with non-traditional liability extending beyond
professional negligence, the most likely outcome will be their
indemnification against such liability via contractual
agreement in conjunction with purchase and installation of the
printers and CAD files. Hospitals and medical practices may
also consider creating separately incorporated entities to own
and operate 3D printers, as is frequently done with other
discrete medical functions such as anesthesiology.330
Third, 3D printing, in the context of using electronic
information from individualized patient scans to create CAD
files for medical devices, could blur distinctions between
professional medical treatment and customized manufacturing
that underlie the learned intermediary doctrine.331 These
considerations gave rise to the first arguable products liability
case involving a 3D-printed product: Buckley v. Align
Technology, Inc.332 Buckley involved 3D-printed, custom-fitted
dental aligners for treating misaligned teeth
(malocclusion).333 The product required a dentists
prescription. The plaintiff in Buckley alleged that the
defendant manufacturer of these 3D-printed devices falsely
advertised, misled and deceived her and other consumers into
believing that [its product] could treat their malocclusions.334
The court dismissed the complaint, applying the learned
intermediary doctrine to the prescription-only 3D-printed
329. See Meribah Knight, 3-D Printing is Revolutionizing Surgery, CRAINS
CHI. BUS. (Mar. 22, 2014), http://www.chicagobusiness.com/article/20140322
/ISSUE01/140229904/3-d-printing-is-revolutionizing-surgery.
330. E.g., Carey Kalmowitz et al., OIG Advisory Opinion 12-06: Insightful
Guidance from the OIG for Structuring Company Model Arrangements, ABA
HEALTH ESOURCE (June 2012), http://www.americanbar.org/content/news
letter/publications/aba_health_esource_home/aba_health_law_esource_0612_k
almowitz.html (discussing various separate-entity anesthesiology business
models).
331. See generally BECK & VALE, supra note 186, at § 2.03.
332. Buckley v. Align Tech., Inc., No. 5:13-cv-02812-EJD, 2015 WL
5698751 (N.D. Cal. 2015).
333. This is the same product referred to in note 230, supra, as well as in
ClearCorrect Operating, LLC v. Intl Trade Commn, 810 F.3d 1283, 1290
(Fed. Cir. 2015), previously mentioned at note 124, supra.
334. Buckley, 2015 WL 5698751 at *1.
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medical device.335 To avoid the doctrine, the plaintiff contended
that the manufacturer necessarily conducted a medical
evaluation of the dental impressions in order to custom fit the
3D-printed device.336 Plaintiff asserted a direct duty to warn
because 3D printing a custom-made medical device was
medical treatment, not mere manufacturing.337 The court
rejected the argument, holding
[t]he [products] are prescribed exclusively by the dentist, and are
custom-manufactured . . . . [I]t appears, thus, that [Defendant]
stands in the position of a manufacturer, not a medical evaluator. As
such, [Defendant] has a duty to warn the dentist about any
dangerous side effects pertaining to the [products] treatment, but
has no duty to directly warn Plaintiff.338
The learned intermediary doctrine barred the plaintiffs
claims in Buckley because the complaint fail[ed] to allege that
her dentist was misled by the manufacturer of the 3D-printed
medical device.339 This reasoning recognized that, although the
3D printing manufacturer played a role in customizing and
fitting medical devices to specific patients, it nonetheless still
functioned as a traditional manufacturer with no direct contact
with the patient, with all direct contact handled by the learned
intermediary prescribers of the product.340 The dental aligner
in Buckley, however, was a relatively simple application of 3D
printing; whether the distinction between medical treatment
and manufacturing can be maintained with respect to more
complex uses of additive manufacturing, such those printed
from living tissue,341 remains to be seen. In such complex
situations, suppliers of 3D-printed products may themselves
argue that they are service providers.342
335. The learned intermediary doctrine provides that in the case of
prescription [products], the duty to warn runs to the physician, not to the
patient. Id. at *3. See also supra note 75 and accompanying text.
336. Buckley, 2015 WL 5698751 at *4.
337. Id.
338. Id. at *4.
339. Id.
340. See Matt Jacobson, First Contact  3D Printing Meets the Learned
Intermediary Rule, DRUG & DEVICE L. BLOG (Oct. 15, 2015), https://www
.druganddevicelawblog.com/2015/10/guest-post-first-contact-3d-printing.html
(discussing Buckley v. Align Tech).
341. See supra notes 20407.
342. Jones & Cavallaro, supra note 86 ([M]anufacturers, particularly
those that sell code for customized devices, such as a custom-orthotic insole,
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As discussed above, since all 3D-printed medical devices on
the market so far have been cleared by the FDA as
substantially equivalent to prior non-3D-printed devices,343
they are having no impact on products liability preemption.344
Once 3D-printed devices are pre-market approved by the FDA,
preemption will depend on whether the FDA has imposed any
requirements on 3D printing.345 Unless and until the FDA
adopts 3D printing regulations, the imposition of FDA
requirements will be by way of the FDAs consideration of
pre-market applications, the specifications of which become
requirements after FDA approval.346 Thus, to shield the 3D
printing process from state-law litigation, manufacturers of
such devices should include specifications for the 3D printing in
their PMA applications. Also, to the extent that a plaintiff
claims that code in a CAD file for any 3D-printed medical
device should have been rewritten to prevent a defect, there
may be impossibility preemption to the extent that the
alteration would be a major or moderate change in the
resultant device that would require FDA preapproval.347
Finally, in the medical device area, manufacturers of the
raw materials or components used in 3D printers may be
protected from liability by the Biomaterials Access Assurance
may also argue that they are providing a professional service as opposed to
a product.) (emphasis in original).
343. Truly novel 3-D printed medical devices probably will get premarket
approval (PMA). Holding back with novel 3-D printed medical devices might
reflect the attitude of many companies to wait for someone else to test the
regulatory waters. Widmer & Dip, supra note 200.
344. Medtronic, Inc. v. Lohr, 518 U.S. 470, 502 (1996) (holding that
preemption is not generally recognized for substantially equivalent devices).
345. Riegel v. Medtronic, Inc., 552 U.S. 312, 321 (2008) (applying 21 U.S.C.
§ 360k(a)).
346. Id. at 318, 319. PMA applications delineate the methods used in, and
the facilities and controls used for, the manufacture[] [and] processing . . . of,
such device[s]. Id. After approval, the statute forbids the manufacturer to
make, without FDA permission, changes in design specifications,
manufacturing processes, labeling, or any other attribute [of the device]. Id.
347. Under Mutual Pharm. Co. v. Bartlett, 133 S. Ct. 2466, 2473 (2013), it
is impossible to comply with both an immediate state-law requirement to
make a safer product and a preemptive federal requirement to obtain FDA
pre-approval before making the same change. See, e.g., Yates v. Ortho-McNeil-
Janssen Pharm., Inc., 808 F.3d 281, 296300 (6th Cir. 2015) (applying Bartlett
outside context of generic drugs).
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Act, provided they register and comply with the Acts other
requirements. 348
VI. CONCLUSION
Although the tort liability implications of 3D-printed
products are still unknown, current laws may need to be
updated or interpreted differently to keep up with this
348. See generally 21 U.S.C. §§ 16011606 (2012). The Biomaterials Access
Assurance Act (BAAA) applies to any civil action brought by a claimant,
whether in a Federal or State court, on the basis of any legal theory, for harm
allegedly caused, directly or indirectly, by an implant. Id. § 1603(b)(1). The
BAAA protects parties who supply either raw materials or component parts
for medical implants (biomaterials suppliers) from the expenses of implant
failure litigation by providing expeditious procedures to dispose of
unwarranted suits against the suppliers. Mattern v. Biomet, Inc., Civil
Action No. 12-4931 (ES), 2013 WL 1314695, at *2 (D.N.J. March 28, 2013)
(quoting 21 U.S.C. § 1601(15)(B)). One such procedure is a motion to dismiss,
which a biomaterials supplier may file under 21 U.S.C. § 1605(a); it provides
that [a] defendant may, at any time during which a motion to dismiss may be
filed under applicable law, move to dismiss an action against it on the grounds
that the defendant is a biomaterials supplier, and if the defendant: (1) is not
liable as a manufacturer; (2) is not liable as a seller; and/or (3) is not liable
for furnishing raw materials or component parts for the implant that failed to
meet applicable contractual requirements or specifications. 21 U.S.C. §
1605(a)(1)(3); see also Whaley v. Morgan Advanced Ceramics, Ltd., No. 07
cv00912, 2008 WL 901523, at *23 (D. Colo. Mar. 31, 2008) (dismissing
biomaterials supplier because it was not the implants manufacturer or seller,
and it did not furnish raw materials or components that failed to meet
contractual requirements or specifications).
Under the BAAA, a biomaterials supplier is defined as an entity
that directly or indirectly supplies a component part or raw material for use in
the manufacture of an implant. 21 U.S.C. § 1602(1)(A). A component part is
a manufactured piece of an implant . . . includ[ing] a manufactured
piece . . . that has significant non-implant applications; and alone, has no
implant value or purpose, but when combined with other component parts and
materials, constitutes an implant. Id. § 1602(3). A raw material is a
substance or product that has a generic use; and may be used in an
application other than an implant. Id. § 1602(8). A seller is defined as a
person who, in the course of a business conducted for that purpose, sells,
distributes, leases, packages, labels, or otherwise places an implant in the
stream of commerce. Id. § 1602(10)(A).
A biomaterials supplier may . . . be liable as a seller . . . only if . . . [it]
held title to the implant and then acted as a seller . . . of the
implant . . . after the initial sale by the manufacturer or acted under
contract as a seller to arrange for the transfer of the implant directly
to the claimant after the initial sale by the manufacturer of the
implant . . . .
Id. § 1604(c)(1).
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emerging technology. As the technology continues to develop
and more and more 3D-printed medical devices are available in
the marketplace, laws and regulations will adapt as they have
for centuries. While 3D printing may disrupt manufacturing as
it is currently known, so did Henry Fords assembly line in the
early 1900s.
Current drug and medical device manufacturers should be
aware of these inadequacies and uncertainties in the law, so
that they can protect themselves from liability going forward.
Manufacturers, whether that term is as traditionally defined or
not, can attempt to reduce potential liability exposure by
developing strategies to manage their product risks through
greater traceability of designs and raw materials. They should
have an open dialogue with their insurers risk managers to
implement a risk management solution.349 Underwriters will
require proof that issues relating to quality control have been
addressed.
As more courts address these issues, new common law will
be created, perhaps expounded in a Restatement (Fourth) of
Torts. However until then, there will undoubtedly be many
issues of first impression.
349.
Product liability is also potentially a big issue in 3D printing to cover
legal liability for damages, a claimants costs and your own costs for
accidental injury or damage caused by products supplied. With an
unorthodox supply chain, accountability and traceability might be
harder [to determine;] so appropriate levels of professional indemnity
cover[age] would be needed . . . .
Insurance Implications of 3D Printing, ZURICH (Aug. 22, 2013), http://insider
.zurich.co.uk/market-expertise/insurance-implications-of-3d-printing/; see also
3-D Printed Products, Product Liability and Insurance Implications, supra
notes 99101 and accompanying text; 3D Printing, a Supply Chain Challenge,
AIRCARGONEWS (July 29, 2016), http://www.aircargonews.net/news/single-view
/news/3d-printing-a-supply-chain-challenge.html.
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